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The protozoan phylum apicomplexa comprises nearly 6000 parasitic species, many of which are 
of significant medical and veterinary importance. Most apicomplexans have adapted to obligate 
intracellular parasitism in a wide range of organisms, including animals and humans. Some 
notable members of the phylum include Toxoplasma, Plasmodium and Eimeria species, which 
collectively impose substantial healthcare and socioeconomic burden worldwide. This study 
focused on three representative parasites, namely Toxoplasma gondii, Eimeria falciformis and 
Plasmodium berghei, all of which infect a common and well-established model host organism (i.e. 
mouse), but have diverged from each other considerably with respect to the target host cells, 
persistence and reproduction behavior. For example, T. gondii can infect and replicate in most 
nucleated cells, whereas P. berghei and E. falciformis are specific to hepatic/red blood cells and 
intestinal epithelial cells, respectively. Unlike Plasmodium and Eimeria species causing only acute 
disease, T. gondii can also inflict chronic infection. Moreover, Toxoplasma can bypass the sexual 
phase for inter-host transmission; in contrast, its peers must undergo alternating asexual and 
sexual growth for the natural transmission. Last but not least, T. gondii and P. berghei display only 
asexual growth in mouse, and require a second host, feline and mosquito, respectively, for sexual 
reproduction, while E. falciformis assumes asexual as well as sexual development in a single host. 
Hence, these parasites together enable a fairly inclusive study of the apicomplexan biology. 
 
A successful intracellular parasite must be able to access host resources and allocate them 
efficiently to satisfy its own cellular demands irrespective of intracellular niche or lifecycle stage. 
Apicomplexan parasites undertake a complex development, which involves genome replication, 
organelle biogenesis and the zoite assembly within other eukaryotic cells (i.e. a eukaryote inside a 
eukaryote). Most developmental stages of these pathogens intimately associate with host cells, 
involving a metabolic crosstalk between the two entwined entities. A germane understanding of 
such interactions is vital to appreciate the evolution of parasites. In a nutshell, this work aimed to 
determine the design of metabolic networks in indicated parasites and the impact of metabolism 
on growth, pathogenesis and adaptation in discrete nutritional milieus. Our approach blended 
bottom-up methods of biochemistry, reverse genetics, cell biology and optogenetics with the top-
down lipidomics, metabolomics and transcriptomics to address the following major premises: 
 
Ø Comparative design of the selected metabolic networks in aforementioned parasites 
Ø Nutritional plasticity underlying the parasite survival in variable environments  
Ø Subversion or exploitation of host metabolism by intracellular parasites 
Ø Stage-specific rewiring of parasite metabolism during asexual reproduction 
Ø Identification and endorsement of potential anti-parasitic drug targets  
 
In a series of work, we have revealed that the tachyzoite stage (fast-replicating acute stage) of T. 
gondii is metabolically very active and rather autonomous in making macromolecules, as well as 
occasionally resilient to nutritional perturbations. Tachyzoites display a surprising plasticity in 
the central carbon metabolism that ensures their survival even in the absence of glucose. We 
identified glutamine and acetate as the two other major carbon sources, which support glucose-
independent growth of tachyzoites. In particular, glutamine-fueled gluconeogenesis becomes 
critical in tachyzoites with impaired glycolysis. The work also illustrated a hitherto unknown 
metabolic convergence between proliferating parasites and cancer cells. In contrast to T. gondii, P. 




entire lifecycle even though the parasite is competent in utilizing glutamine and acetate. Inability 
of P. berghei to survive without glucose is due to absence of glutamine-powered gluconeogenesis. 
 
In additional work, we show that T. gondii and E. falciformis harbor a nearly complete enzymatic 
machinery to make major phospholipids and thus seem to be fairly autonomous of respective 
host cell. Toxoplasma displays a flexible membrane biogenesis, which along with malleable carbon 
flux partly explains its promiscuous growth in assorted host milieus. Our data also demonstrate 
significant and unexpected divergence in several aspects of lipid biogenesis, not only with respect 
to mammalian hosts but also within the phylum apicomplexa. We observed that tachyzoites of T. 
gondii and the sporozoite stage of E. falciformis express exclusive sphingolipids, ethanolamine-
phosphorylceramide and inositol-phosphorylceramide, respectively. Equally, we identified a 
novel and major phospholipid expressed in T. gondii and E. falciformis (but not in Plasmodium and 
mammalian cells), termed phosphatidylthreonine, which has evolved from an otherwise-universal 
lipid, phosphatidylserine. A tachyzoite mutant lacking phosphatidylthreonine exhibits impaired 
calcium homeostasis, which in turn compromises the lytic cycle and virulence. Notably, such a 
metabolically attenuated parasite strain can be used as a vaccine to prevent toxoplasmosis in a 
mouse model. The natural expression and specialized functions of phosphatidylthreonine and 
indicated sphingolipids signify adaptive divergence of membrane lipids in parasitic protists, which 
offers an attractive intervention strategy to selectively inhibit the parasite reproduction. 
 
Our active engagement with E. falciformis has also identified the host determinants of infection in 
vivo. We have discovered a retinue of IFNγ-regulated host factors, e.g., tryptophan catabolism, 
immunity-related GTPases and chemokine signaling, some of which are protective, whereas 
others are evaded or even exploited by the parasite. This study found how mouse IFNγ-signaling 
plays opposing roles in promoting and demoting the Eimeria development. Especially, induction 
of the first enzyme of tryptophan catabolism (indoleamine 2,3-dioxygenase) in the mouse caecum 
is needed for efficient in vivo growth of E. falciformis. Likewise, we show a requirement of host cFos 
(a proto-oncogenic master transcription factor) for in vitro growth of E. falciformis and T. gondii. 
Finally, as reckoned necessary to resolve our above-mentioned paradigms, we established new or 
improved methods. For example, we applied optogenetics to regulate cyclic nucleotide-directed 
signaling in T. gondii, which enabled an otherwise-challenging induction of the parasite cAMP in 
a specific, reversible and spatiotemporal manner without perturbing the surrounding host cells. 
Using this tool, we determined a requisite of cAMP for the parasite differentiation and associated 
gene expression. Besides, by employing an optogenetic sensor (gene-encoded calcium indicator), 
we discovered the importance of phosphatidylthreonine in regulating the cytosolic calcium pool 
in intracellular tachyzoites. In brief, optogenetically-modified strains allow a more systematic 
dissection and detection of the signaling cascades in intracellular parasites, which has not been so 
feasible when using chemical modulators and probes. Our initial application of light-responsive 
actuators and sensors to illuminate the parasite biology is expected to lead a wider deployment of 








Das zu den Protozoen gehörende Phylum der Apicomplexa umfasst nahezu 6000 Parasitenarten, von 
denen einige von medizinischer und veterinärmedizinischer Bedeutung sind. Die meisten 
Apicomplexa haben sich an eine obligat intrazelluläre Lebensweise angepasst und infizieren 
verschiedenste Tiere und den Menschen. Zu den bedeutendsten Vertretern der Apicomplexa zählen 
Toxoplasma, Plasmodium und Eimeria, welche eine wesentliche Belastung für das Gesundheitswesen und 
Sozioökonomie darstellen. In dieser Arbeit lag der Schwerpunkt auf den drei repräsentativen 
Organismen Toxoplasma gondii, Eimeria falciformis und Plasmodium berghei, welche sich alle in einem 
etablierten Wirt (der Maus) reproduzieren, sich allerdings hinsichtlich ihrer Wirtszellen, Persistenz 
sowie in ihrem Reproduktionsverhalten deutlich unterscheiden. T. gondii infiziert beispielsweise 
nahezu alle kernhaltigen Zellen, während P. berghei und E. falciformis spezifisch Leber- und Blutzellen 
bzw. Darmepithel befallen. Plasmodium und Eimeria verursachen ausschließlich akute Erkrankungen, 
eine Infektion mit Toxoplasma kann auch chronisch verlaufen. Im Gegensatz zu Plasmodium und 
Eimeria, die den Wechsel zwischen sexueller und asexueller Vermehrung bei der natürlichen 
zwischenwirtlichen Transmission durchlaufen müssen, kann Toxoplasma die sexuelle Phase umgehen. 
Letztlich vermehren sich T. gondii und P. berghei in der Maus ausschließlich asexuell und benötigen 
einen zweiten Wirt (Katzen bzw. Moskitos) für die sexuelle Reproduktion, während E. falciformis 
sowohl die sexuelle als auch die asexuelle Phase in der Maus durchläuft. Somit ermöglichen die 
genannten Parasiten eine umfassende Untersuchung der Biologie der Apicomplexa. 
 
Ein erfolgreicher intrazellulärer Parasit muss in der Lage sein auf Ressourcen des Wirts zuzugreifen 
und diese für den eigenen zellulären Bedarf zu nutzen. Apicomplexe Parasiten durchleben eine 
komplexe Entwicklung einschließlich Genomreplikation, Organellen- und Tochterzellbildung in 
einer anderen eukaryotischen Zelle. Die meisten Entwicklungsstufen dieser Pathogene sind sehr eng 
mit der Wirtszelle assoziiert, was auch metabolische Wechselwirkungen beinhaltet. Das Verständnis 
dieser Interaktionen ist unerlässlich, um die Evolution von Parasiten zu ergründen. Grundsätzlich 
war das Ziel dieser Arbeit, die metabolischen Netzwerke der genannten Parasiten zu eruieren und 
den Einfluss des Metabolismus auf Wachstum, Pathogenese und Adaption in verschiedenen 
Nährstoffumgebungen zu untersuchen. Unsere Vorgehensweise verband biochemische, revers-
genetische, zellbiologische und optogenetische Bottom-Up-Methoden mit Top-Down-Methoden wie 
Lipidomics, Metabolomics und Transcriptomics um folgende Prämissen anzugehen: 
 
• Vergleichender Entwurf der metabolischen Netzwerke in den obengenannten Parasiten 
• Nährstoff-Plastizität für die Überlebensfähigkeit des Parasiten in verschiedenen Milieus  
• Umregulierung oder Ausbeutung des Wirtsmetabolismus durch intrazelluläre Parasiten 
• Stadien-spezifische Regulation des Metabolismus während der asexuellen Reproduktion 
• Identifizierung und Validierung potentieller anti-parasitischer Wirkstoffe 
 
In unserer bisherigen Arbeit haben wir gezeigt, dass das Tachyzoiten-Stadium (akute Form der 
Infektion) von T. gondii metabolisch sehr aktiv, weitgehend autonom in der Biogenese von zellulären 
Makromolekülen und mitunter sehr widerstandsfähig bei variierender Nährstoffverfügbarkeit ist. 
Tachyzoiten zeigen eine enorme metabolische Plastizität im zentralen Kohlenstoffmetabolismus, 
welche sogar ein Überleben ohne Glukose ermöglicht. Weiterhin konnten wir nachweisen, dass 
Glutamin und Acetat zwei weitere bedeutende Kohlenstoffquellen neben Glucose darstellen. Vor 
allem die glutamingetriebene Gluconeogenese wirkt sich entscheidend auf Tachyzoiten mit einer 
beeinträchtigten Glykolyse aus. Diese Untersuchungen zeigten eine bisher unbekannte metabolische 




darauf angewiesen Zucker des Wirts in seinem gesamten Lebenszyklus zu importieren, weil die 
Gluconeogenese fehlt, obwohl der Parasit auch fähig ist Glutamin und Acetat zu nutzen. 
 
Wir zeigten zudem, dass sowohl T. gondii als auch E. falciformis eine nahezu vollständige Enzymkette 
für die Biosynthese der wichtigsten Phospholipide beherbergen und somit ziemlich unabhängig von 
ihrer jeweiligen Wirtszelle zu sein scheinen. Toxoplasma zeigt eine flexible Membranbiogenese, welche 
zusammen mit einem variablen Kohlenstofffluss zum Teil seine Wachstumsfähigkeit in verschiedenen 
Nährstoffmilieus erklärt. Darüber hinaus demonstrieren unsere Ergebnisse eine erhebliche sowie 
unerwartete Divergenz hinsichtlich der Stoffwechselwege zur Membranbiogenese - sowohl in Bezug 
auf den Säugerwirt aber vor allem auch innerhalb der Apicomplexa. Wir konnten beobachten, dass 
Tachyzoiten von T. gondii und Sporozoiten von E. falciformis exklusive Sphingolipide, Ethanolamin-
Phosphorylceramid bzw. Inositol-Phosphorylceramid, bilden. Darüber hinaus konnten wir ein bisher 
unbekanntes Phospholipid Phosphatidylthreonin identifizieren, welches in T. gondii und E. falciformis 
exprimiert ist (jedoch nicht in Plasmodium und Säugern) und sich aus dem anderweitig universellen 
Phosphatidylserin entwickelt hat. Die Tachyzoit-Mutante, der dieses exklusive Lipid fehlt, zeigt eine 
gestörte Kalziumhomöostase, welche wiederum den lytischen Zyklus sowie die Virulenz des Parasiten 
beeinträchtigt. Bemerkenswerterweise kann ein solcher metabolisch attenuierter Parasitenstamm als 
Impfstoff verwendet werden und so eine Erkrankung an Toxoplasmose im Mausmodell verhindern. 
Die Expression und spezialisierten Rollen von Phosphatidylthreonin und der angegebenen 
Sphingolipide kennzeichnen eine adaptive Divergenz der Membranlipide in parasitischen Protisten, 
welche einen attraktiven Angriffspunkt für die selektive Inhibierung des Parasiten-Wachstums liefert. 
 
Unsere Untersuchungen an E. falciformis waren erfolgreich hinsichtlich der bestimmenden Faktoren 
in Bezug auf den Wirt in vivo. Dabei haben wir eine Reihe IFNγ-regulierter Stoffwechselwege im 
Wirt, wie beispielsweise den Tryptophan-Katabolismus, mit der Immunität in Zusammenhang 
stehende GTPasen sowie eine Chemokin-Signaltransduktion, entdeckt, von denen einige eine 
protektive Wirkung haben, anderen wiederum kann der Parasit entkommen oder diese sogar 
ausnutzen. Unsere Arbeit zeigt, wie die IFNγ-Signalgebung in der Maus entgegengesetzte Rollen im 
Fördern und Schaden der Entwicklung von Eimeria spielt. Insbesondere ist die Induktion des ersten 
Enzyms des Tryptophan-Katabolismus (Indoleamin-2,3-Dioxygenase) im Darm der Maus für ein 
effizientes Wachstum von E. falciformis notwendig. Gleichzeitig konnten wir den Bedarf an Wirts-cFos 
(ein proto-onkogener Haupttranskriptionsfaktor) für die in vitro-Entwicklung von E. falciformis und T. 
gondii aufzeigen. Schlussendlich etablierten wir neue und verbesserte Methoden, um die genannten 
Problemstellungen anzugehen. So nutzten wir beispielsweise optogenetische Methoden, um die 
Signalkaskaden zyklischer Nukleotide in T. gondii in einer spezifischen, reversiblen und raum-zeitlich 
definierten Weise zu manipulieren, ohne die Wirtszelle zu beeinflussen, was sich bisher als schwierig 
erwies. Mit dieser Methode konnten wir den Bedarf von cAMP für die Stadien-Differenzierung und 
assoziierte Genexpression aufzeigen. Weiterhin haben wir mit Hilfe dieses optogenetischen Sensors 
(ein gencodierter Kalziumindikator) eine Funktion von Phosphatidylthreonin bei der Regulation des 
zytosolischen Kalziums in intrazellulären Tachyzoiten entdeckt. Kurz gesagt ermöglichen solche 
optogenetisch veränderten Stämme eine systematischere Aufschlüsselung bzw. Detektion von 
Signalkaskaden in intrazellulären Parasiten, was bisher allein durch chemische Untersuchungen nicht 
möglich war. Unsere Anwendung Licht-responsiver Akteure und Sensoren zur näheren Beleuchtung 








ACS Acetyl CoA synthetase 
CCT CTP:phosphocholine cytidylyltransferase 
CDP-DAG CDP-diacylglycerol 
CDS CDP-DAG synthase 
CK Choline kinase 
cNMP Cyclic nucleotide monophosphate (cAMP, cGMP)  
CPT Choline phosphotransferase 
DAG Diacylglycerol 
DG Dense granule 
DLC Dynein light chain 
DME Dimethylethanolamine 
ECT CTP:phosphoethanolamine cytidylyltransferase 
EK Ethanolamine kinase 
EPC Ethanolamine-phosphorylceramide 
EPT Ethanolamine phosphotransferase 
ER Endoplasmic reticulum 
FAS/FAE Fatty acid synthase / Fatty acid elongase 
FBP Fructose 1,6-bisphosphatase 
G3P Glycerol-3-phosphate 
GBP Guanylate-binding protein  
GRA Granule (proteins secreted by dense granules)  
GT1 Glucose transporter 1 
HT1 Hexose transporter 1 
IDO Indoleamine 2,3-dioxygenase 
IPC Inositol-phosphorylceramide 
IRG Immunity-related GTPase 
LDL Low density lipoprotein 
MIC Microneme (or proteins secreted by micronemes) 
MNN Membranous nanotubular network 
PDME Phosphatidyldimethylethanolamine 
PECK Phosphoenolpyruvate carboxykinase 
PIS Phosphatidylinositol synthase 
PKA Proteins kinase A (cAMP-dependent)  
PKG Protein kinase G (cGMP-dependent) 
PSD Phosphatidylserine decarboxylase 





PtdOH Phosphatidic acid 
PtdSer Phosphatidylserine 
PtdThr Phosphatidylthreonine 
PTS Phosphatidylthreonine synthase 
PV/PVM Parasitophorous vacuole / PV membrane 
RON Rhoptry neck (proteins located in the rhoptry-neck region) 
ROP Rhoptry or proteins located in the rhoptry-bulb region 
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1.1  Parasitism and its impact in nature 
The organisms in an ecosystem interact in different ways, which may exert positive, neutral or 
negative impact on each other. The term symbiosis usually refers to these interactions between 
two (or more) organisms living together with some sort of feeding relationship involved [1,2] (Fig 
1). The three commonly observed symbiotic interactions are mutualism, in which both organisms 
benefit; commensalism, where one of the two partners benefits, while the other organism is not 
harmed; and parasitism, where one (parasite) profits at the expense of other (host) organism [1,2]. 
Parasites typically depend on host resources for the survival. They may live outside (ectoparasite) 
or inside (endoparasite) a host [3]. An endoparasite spends significant part of its life inhabiting on 
tissues (extracellular) or within cells (intracellular) of a host organism.  
 
 
Fig 1: Emoticon illustration of three major symbiotic relationships observed in nature. Unlike mutual and commensal 
interactions between the two organisms, in which both or at least one partner gains and none are harmed, 
a parasitic relationship involves an inverse association. 
 
Although the concept of parasitism and the term parasite apply unambiguously to many cases in 
nature, e.g., bacteria and viruses, they generally entail to eukaryotic pathogens of protozoan and 
metazoan origins. The kingdom protozoa comprises more than 40,000 known living species, of 
which about 25,000 species occur as free-living, whereas the remaining are adapted to parasitic 
life [4,5]. The latter group includes at least 250 amoebae, 1800 flagellate, 2500 ciliate and 6000 
sporozoan (apicomplexan) species. These parasitic organisms together impose significant burden 
on our healthcare systems worldwide. Not only do they affect infected hosts by altering growth, 
behavior, nutritional status, reproductive abilities and mortality, but also shape our ecosystem by 
influencing trophic interactions, food webs and biodiversity [6]. 
 
1.2 Obligate intracellular (apicomplexan) parasites 
The phylum apicomplexa contains the bulk of what was once termed as the sporozoa, a group of 
spore-forming parasitic protozoans lacking pseudopods and cilia altogether, and flagella from the 
most lifecycle stages [7,8]. They have likely evolved from a photosynthetic algal ancestor [9]. A 
transition from the free-living to parasitic lifestyle is supported by the existence of closely related 
predator (colpodellids) and symbiont (Nephromyces) of marine organisms [10,11]. The apicomplexan 
members have adapted to become mostly obligate intracellular parasites with complex lifecycles, 




ubiquitously distributed across the animal kingdom. They can be grouped based on phylogenetic 
relationships and tissue specificities [12,13] (Fig 2). Hematozoans infect blood cells of a vertebrate 
host to achieve the asexual reproduction and require a blood-feeding invertebrate host for sexual 
reproduction and transmission. The well-known hematozoans include Plasmodium species causing 
malaria, along with Babesia and Theileria species, which infect cattle [3]. The coccidian parasites, 
forming the largest group in the phylum, typically infect intestinal and extra-intestinal tissues and 
spread through the fecal-oral route. Some of the prevalent coccidian genera include Toxoplasma, 
Sarcocystis, Eimeria, Isospora and hepatozoon that infect animals and/or humans [14]. In particular, a 
single species of Toxoplasma (T. gondii) is capable of infecting nearly all warm-blooded organisms 
[15]. On the other hand, individual species of the genus Eimeria (>1800 species) are highly host-
specific and cause diarrhea in a variety of animals, most notably in the poultry [16]. Gregarine is 
a distant subgroup, which consists of primarily extracellular pathogens of invertebrates [17], but 





























Fig 2: Phylogenetic tree of apicomplexan parasites. Only representative parasite groups (e.g., hematozoa, coccidia 
and gregarines) are depicted. Numbers and thickness of branches indicate the approximate diversity (i.e. 
known species) in each clade. The hallmark features and common parasite members are also mentioned. 
Apicomplexans have evolved from a photosynthetic ancestor (chromerids). They are closely related to free-
living predators (colpodellids) and endosymbionts (Nephromyces). Cryptosporidium likely emerged from within 




1.3 Lifecycle of apicomplexan parasites  
The natural lifecycle of apicomplexan parasites comprises both asexual and sexual reproduction 
gyrating often between the primary (i.e. definitive or sexual) and secondary (i.e. intermediate or 
asexual) hosts [3,14] (Fig 3). Toxoplasma and Plasmodium species complete their entire development 
in two hosts (dixenic), while Eimeria and Cryptosporidium species require only one host (monoxenic) 
(Fig 2). Plasmodium, Eimeria and Cryptosporidium species are very specific to the host, tissue and cell 
types they infect; conversely, T. gondii is quite promiscuous with little to no regard to any of these. 
Infective stages of the apicomplexan parasites are termed as zoites that are formed after sexual 
(sporozoite) or after asexual (merozoite, tachyzoite, bradyzoite etc.) reproduction [14,19]. Asexual 
growth of zoites is followed by sexual development producing male and female gametes that fuse 
together to form a zygote, which later develops into an oocyst. The oocyst stage undergoes the 























Fig 3: Simplified lifecycle of apicomplexan parasites. Only the most generic type lifecycle and underlying stages 
are depicted. Many deviations are seen in nature, particularly with respect to the asexual development. As 
illustrated, lifecycle is completed either in one or two hosts (dotted line). Most developmental stages of the 
apicomplexan parasites are haploid except for the oocyst, which is diploid. Inter-host transmission usually 
requires the entire cycle, which initiates with the formation of sporozoites within oocysts via sporogony (a 
type of meiosis). Asexual reproduction occurs generally by schizogony (a type of mitosis). Some parasites 




Asexual reproduction of Plasmodium in its intermediate host begins with the injection of infective 
sporozoites by the primary host, mosquito [20]. Sporozoites infect and reproduce in hepatocytes, 
which eventually release thousands of merozoites into bloodstream. Merozoites replicate in red 
blood cells by multiple rounds of erythrocytic schizogony. A fraction of merozoites differentiates 
into gametes, which undergo sexual commitment to ultimately yield the sporulated oocysts in the 
mosquito host. Lifecycle of Eimeria species initiates with the ingestion of sporulated oocysts from 
the environment, ensued by infection of intestinal epithelium with freed sporozoites, schizogony, 
gamogony and oocyst development, all occurring in one host [14]. In the case of Toxoplasma, the 
secondary hosts get infected either by ingesting oocysts containing sporozoites from environment, 
or by tissue cysts harboring bradyzoites (present in infested meat), both of which differentiate into 
tachyzoites in intestinal epithelium [21]. Tachyzoites undertake lytic cycles causing tissue necrosis 
and then spread to immunoprivileged sites (brain, eyes, muscles etc.) before forming bradyzoites. 
Bradyzoites can start either schizogony producing merozoites and then sexual reproduction upon 
predation of a chronically-infected secondary host by a primary host, or alternatively can resume 
asexual growth as tachyzoites when ingested by another secondary host [21]. Hence, Toxoplasma 
is unique in its ability to bypass the sexual phase and transmit from asexual to asexual hosts. 
 
1.4 Structure and morphology of an apicomplexan zoite 
A plethora of intracellular pathogens have evolved to invade and develop in host cells; however, 
only few would contest the subcellular complexity observed in apicomplexan zoites. The zoite is a 
highly polarized cell delimited by the pellicle, a tri-bilayer alveolate-specific structure comprising 
plasma membrane and inner membrane complex (Fig 4). Underneath the pellicle are the apical 
and basal complexes, located at the anterior and posterior ends, respectively [22]. The pellicle is 
associated to the subpellicular microtubule network, which acts as the parasite skeleton [22]. The 
inner membrane complex extends from the apical to the basal complex, and harbors the gliding 
machinery to drive the actin-myosin-dependent parasite motility. The parasite body contains a 
multitude of dedicated organelles, which enable it to perform the sequential tasks of invasion and 
subsequent development [23,24]. In short, a mature zoite is designed to identify and invade the 
target host cell, proliferate intracellularly, and often differentiate into the next lifecycle stage [23].  
 
The apical complex is an emblematic feature of the phylum, though its constituents vary among 
members. It consists of the parasite-specific secretory organelles, microneme and rhoptry, and a 
polar ring (Fig 4). In coccidians, the apical complex also comprises the conoid – a cylinder-like 
structure of spirally-arranged tubulin – that is extended during gliding motility and invasion. The 
parasite contains many exclusive organelles (rhoptries, micronemes, dense granules, apicoplast, 
plant-like vacuole, acidocalcisomes, exonemes, refractile bodies) as well as the typical eukaryotic 
organelles (nucleus, mitochondrion, centriole, Golgi body, endoplasmic reticulum) [14,19]. Some 
of these are parasite or even stage-specific, e.g., plant-like vacuole in Toxoplasma [25], food vacuole 
and exonemes in Plasmodium [26,27] and refractile bodies in Eimeria [28]. Differences in the 
organelle makeup of each parasite or stage generally correlate with the specialized behavior and 




is in fact a vestigial chloroplast of algal origin acquired by secondary endosymbiosis [31,32]. It is 
present in most members of the phylum except for gregarines (Fig 2). The apicoplast has lost the 
















Fig 4: Schematic illustration of a zoite. Only the organelles conserved across most parasites are depicted. Not 
every structure shown here occurs in all apicomplexan parasites. The morphology of individual zoites may 
differ from the depiction, which signifies the tachyzoite stage of T. gondii (sporozoite, slender elongated; 
merozoite, oval to slender elongated; tachyzoite, crescent; bradyzoite, crescent to elongated; ookinete, 
oval-elongated). To see a merozoite of P. falciparum (within a red blood cell), please refer to Figure 7. AC, 
acidocalcisome; CE, centrosome; CO, conoid; DG, dense granule; ER, endoplasmic reticulum; IMC, 
inner membrane complex; MIC, microneme; MT, microtubule 
 
1.5 Asexual reproduction in apicomplexan parasites   
The pathology caused by individual parasites is due to multiple rounds of asexual reproduction, 
often leading to host-cell lysis, tissue necrosis and inflammation. Acute infection occurs by serial 
lytic cycles that involve invasion, replication, parasite egress and subsequent infection of nearby 
cells (Fig 5). Once attached and apically oriented onto the host cell surface, the parasite invades 
within a minute, enclosed in a special membranous structure termed the parasitophorous vacuole 
(PV) [35,36]. Events of invasion and intracellular establishment require an orchestrated secretion 
of micronemes, rhoptries and dense granules. Secreted proteins enable several functions that 
include motility, invasion, maturation of the PV, egress and defense against the host-cell insults 
[30]. Mechanisms of invasion and formation of nascent PV are mostly conserved since these are 
regulated by a fairly conserved set of micronemal (MIC) and rhoptry-neck (RON) proteins [37–
40]. However, the way each parasite manipulates its host differs considerably due to divergence 
in rhoptry-bulb (ROP) and dense granule (GRA) proteins. The ROP and GRA proteins contrast 

















Fig 5: Asexual reproduction in apicomplexan parasites as exemplified for the tachyzoite stage of T. gondii. The zoite stage 
invades the host cell, proliferates to form progeny, which egress to begin a new lytic cycle (acute infection). 
Sporozoites and bradyzoites differentiate into the next stage during the asexual growth, while tachyzoites 
and merozoites do not always undergo stage switching. Most zoites divide in a parasitophorous vacuole 
except for Theileria, Babesia and Sarcocystis species, which escape the nascent vacuole to eventually reside in 
the cytosol. Physicochemical and immune stresses cause certain parasites, notably Toxoplasma and Neospora, 
to assume dormancy as tissue cyst (chronic infection), which may reactivate upon declined stress to initiate 
the lytic cycle (recrudescence). Calcium and cyclic nucleotides are the two core regulators of the lytic cycle 
and stage differentiation. Some parasites (Plasmodium, Babesia) infect non-nucleated host cells. 
 
Successive phases of intracellular replication ultimately cause parasites to egress by lysing the host 
cell, which occurs after variable number of cell cycles depending on the parasite and host cell. In 
most apicomplexans, egress is a signaling-mediated active process that involves timely sensing of 
the host environment by the parasite [41–43]. Perturbation of ion homeostasis in the dying host 
cell and activation of calcium- and cGMP-dependent signaling in the parasite are among many 
other factors governing the gliding motility and subsequent egress and invasion events. Immune 
response and physicochemical stress can trigger encystation of certain parasites into tissue cysts 
[21] (Fig 5), which remain latent until reactivated under favorable condition, such as weakened 
immunity. The apicomplexans have evolved distinct strategies to execute their cell cycles, which 
are designed to ensure that progeny are mature enough to initiate a new lytic cycle or further 
development [44] (Fig 6). Merozoites of Plasmodium, Eimeria and Toxoplasma assume schizogony; in 
which cytokinesis does not instantly follow karyokinesis. Instead, many cycles of DNA replication 
and nuclear divisions produce a schizont stage prior to the assembly of several zoites. Toxoplasma 
tachyzoites divide by endodyogeny, a variant of schizogony, where karyokinesis and cytokinesis 
proceed soon after DNA replication. Unlike schizogony, endodyogeny yields only two cells per 




constituents and regulators. It appears to be regulated globally as well as locally, especially in the 
schizont stage. Global regulation is exerted by diffusible proteins, such as transcription factors, 




















Fig 6: Cell division in apicomplexan parasites. Only two usual modes of asexual growth (Plasmodium, Eimeria and 
Toxoplasma) are shown. Schizogony: many rounds of DNA replication and nuclear divisions precede budding 
of daughter cells at the plasma membrane. Endodyogeny: one cycle of DNA replication and nuclear division 
are immediately followed by budding of two progeny within the mother-cell cytoplasm. Image is adapted 
from the reference [44]. Centrosome, yellow circles; inner membrane complex, brown; nucleus, blue 
 
1.6 Parasitophorous vacuole and remodeling of infected host cell 
Nearly all zoites except for some hematozoan blood stages infect biosynthetically active host cells, 
which often include even the immune cells (dendritic cells, macrophages, lymphocytes) [45]. The 
parasites’ foremost tasks are therefore to escape lysosomal fusion and cell-intrinsic immunity, and 
intercept nutrients. To accomplish all these, they extensively manipulate their respective host cell. 
Individual members differ in relationship with intracellular niches, which is mainly dictated by 
rhoptry-bulb and dense granule proteins [39,40]. Most parasites develop within a PV, which is 
initially derived from the host plasma membrane during the process of invasion but significantly 
modified to safeguard the parasite development [46–49]. The mature PV does not intersect with 
the endocytic and exocytic traffic and avoids lysosomal acidification. As known in T. gondii [47], 
the PVM forms deep invaginations into the intravacuolar space and long extensions in the host 
cytosol (Fig 7). The PV of tachyzoites physically tethers with the host endoplasmic reticulum and 
mitochondria, and recruits cytoskeleton [50]. Interaction of the PVM with the host ER (but not 
mitochondria) has also been reported in hepatic cells infected with Plasmodium sporozoites [51]. 
Likewise, the merozoite stage induces the formation of Maurer’s clefts (flat membrane structures), 
PVM extensions and cytoskeleton rearrangements in the erythrocyte cytosol along with knob-like 
structures and new permeation pathway on the surface [52–54] (Fig 7). Many other variations in 










































Fig 7: Remodeling of host cells induced by Toxoplasma and Plasmodium. Images exemplify only selected aspects. 
Top panel: Toxoplasma tachyzoites in a nucleated mammalian cell. Intravacuolar space is decorated with the 
membranous nanotubular network (MNN). Extensions of PV into host cytosol (tubulovesicular network or 
TVN) and intravacuolar invaginations of the PVM (i.e. Host Organelle Sequestering Tubules; HOST) are 
also shown. The host-cell ER, mitochondria and cytoskeleton (tubulin, vimentin) become rearranged onto 
the PVM. Bottom panel: A Plasmodium merozoite in an erythrocyte. The parasite induces the formation of 
Maurer’s cleft, membrane loops, TVN, knob-like structures (as depicted), as well as cytoskeletal alterations 
and new permeation pathway (not shown) in the infected cell. Unlike T. gondii tachyzoites, where the PV is 
the main destination for most rhoptry-bulb and dense granule proteins, the PV of Plasmodium merozoites 
constitutes a mandatory transit point for the protein cargo en route to host erythrocytes. DG, dense granule; 




In addition to specified morphological alterations, infection of host cells with individual parasites 
also results into transcriptomic and proteomic modulation of distinct pathways, such as protein 
synthesis, metabolism, immune signaling, membrane trafficking, intrinsic immunity, apoptosis, 
antigen presentation and microRNA [55–64]. It appears as though a personalized manipulation 
of the host environment by each parasite is imperative to ensure its survival and reproduction. 
 
1.7 Nutritional basis of intracellular parasitism 
Most apicomplexans during their entire intracellular phase are sheltered within a non-fusogenic 
vacuole, which shields from host defense, but also restricts them from retrieving metabolites (Fig 
8). Parasites have therefore invented ingenious strategies; for example, Toxoplasma, Plasmodium and 
Eimeria remodel their PVM as such to make it permeable to small molecules [65–67]. The PVM 
of T. gondii tachyzoite harbors Gra17 and Gra23 proteins, which enable diffusion of molecules up 
to 1.3-kDa [65,68]. The PVMs of erythrocytic and hepatic stages of Plasmodium also function as 
molecular sieves allowing the passage of metabolites below 1.4-kDa and 0.85-kDa, respectively 
[51,66]. Plasmodium merozoites also modify the permeability of erythrocyte plasma membrane to 
obtain a wide range of nutrients from the blood milieu [69,70]. These membrane sieves are very 
vital for salvaging those nutrients that parasites are unable to produce themselves, as well as for 













Fig 8: Abridged depiction of metabolic interactions in a parasite-infected cell. Most parasites are separated from 
exogenous nutrients by at least three physical barriers including the plasma membranes of the host cell 
and parasite, as well as the parasitophorous vacuole membrane. Exemplary flow of metabolic substrates 
(S) and waste (W) across these membranes and putative transporters are shown. Just as any other cell, 
parasites require biomass, energy, cofactors, reducing equivalents, ion homeostasis and nutrient stores for 
reproduction; however, how they fulfill these metabolic necessities differs considerably. Depending on the 




In free-living organisms, the linked pathways of central carbon metabolism (glycolysis, pentose 
phosphate shunt, TCA cycle) constitute a metabolic hub to ensure the biomass, energy and redox 
demands during cell proliferation and differentiation [71,72]. While intracellular parasitism has 
resulted in a net loss of metabolic pathways in apicomplexans, these three core pathways remain 
conserved in most intracellular parasites [9]. Evenly, parasites have also often preserved synthesis 
of fatty acids except for few (e.g., Theileria), which appear to be auxotrophic [73]. Toxoplasma and 
Eimeria genomes also encode pathways to produce most amino acids [74]. By contrast, Plasmodium 
merozoites cannot produce them and satisfy their demands for amino acids largely by degrading 
erythrocyte-derived hemoglobin in food vacuole [75]. Except for the cytostome-mediated uptake 
of hemoglobin [76,77], there is no tangible evidence for a typical endocytosis-mediated import in 
apicomplexans [78]. Hence, once across the PV sieve, metabolites translocate to the parasite via 
substrate-specific transporters located in the plasma membrane. Indeed, these parasites encode a 
large repertory of transporters (www.membranetransport.org) (Table 1). 
 
Metabolism is also among one of the most affected functional categories in transcriptomics and 
proteomics studies of host cells infected with Eimeria, Toxoplasma and Plasmodium species, as well as 
in intracellularly-residing parasites [55,57–59,64,79–81]. These data suggest a robust importance 
of metabolic interactions between the parasite and host cell. The types of metabolism-associated 
proteins modulated in parasitized host cells include carbohydrate, lipid and nucleotide pathways, 
which match across infections. It is also postulated that host mitochondria and ER may donate 
multiple nutrients to the developing parasites [82], such as lipids, sugar-phosphates, amino acids, 
fatty acids, glycan intermediates and lipoic acid. Although pending a direct proof, tachyzoites of 
Toxoplasma may also salvage a range of metabolites (metals, sulfate, lipids, amino acids, sugars) by 
selectively intercepting the host vesicles via HOST structures [83] (Fig 7). Not much is known 
about Eimeria species, but given the phylogenetic proximity, their metabolic crosstalk with 
respective host cells is likely to resemble T. gondii, excluding niche-specific variations. Theileria and 
Babesia escape the PV immediately after invasion and divide in the cytoplasm of lymphocytes and 
erythrocytes, respectively. These parasites have more direct access to host-derived nutrients that 
resonates with their much lower metabolic potential than peers [45]. 
 
1.8  Overarching theme and underlying paradigms 
Infection, pathogenesis and transmission of apicomplexan parasites depend on distinct abilities of 
individual pathogens to switch lifecycle stages and exploit host-cell resources including nutrients. 
By examining how parasites interact with and respond to the nutritional milieus encountered in 
their host cells, one can learn how to selectively inhibit them. Apicomplexan parasites have much 
smaller genomes (Table 1), which signifies that they are under different selective pressures when 
compared to free-living counterparts. In context of this work, our genome-wide comparisons are 
indicative of a strong evolutionary influence of metabolism in shaping the world of apicomplexan 
parasites. They have gained or lost selected metabolic pathways, while optimizing their lifecycles 
with individual host through the long path of co-evolution. Toxoplasma, Plasmodium and Eimeria for 




hosts, human and mouse, encoding for approximately 5000 enzymes (Table 1). An equally strong 
variance with similar pattern is also observed when comparing the number of unique proteins 
and transporters. In essence, it reflects multiple metabolic dependencies of designated parasites, 
which may underlie their ultimate adaptation to a strictly intracellular parasitic lifestyle. 
 
Table 1: Genome-wide comparisons of selected apicomplexan parasites and mammalian hosts 
 
Organisma Genome size (Mb) 
Total genes  
(Unique proteins) 
Enzymes 
(with EC #) 
Transporters  
(# with GO term) 
Toxoplasma gondii (ME49) 64 8920 b 1700 b 304 b 
Plasmodium falciparum (3D7) 23 5777 b 1311 b 406 b 
Eimeria tenella (Houghton) 60 8634 b 1556 b 216 b 
Homo sapiens (Human) 3300 23287 (87222) c 4974 d 2725 d 
Mus musculus (mouse) 2800 22796 (45557) c 4852 d  2361 d 
a Only one representative species of each organism is shown. 
b Deduced from the parasite genome databases, www.ToxoDB.org and www.PlasmoDB.org. 
c Extracted from The Global Proteome Machine Database (www.thegpm.org). 
d As annotated in UniProt Database (www.uniprot.org).  
 
Asexual reproduction of parasites within host cells is achieved by consecutive lytic cycles. A single 
parasite can usually produce 16-64 daughter cells within a nonfusogenic vacuole, which serves as 
a safe residence for reproduction. Such an efficient replication and concomitant expansion of the 
PV requires significant nutritional import and synthesis of macromolecules within the parasite. A 
number of metabolic precursors are likely transported and utilized to produce biomass. However, 
the mechanisms of import and subsequent metabolic usage of many such nutrients by parasites 
(metabolic potential) are very much underappreciated. In addition, it is not well understood how 
the parasite metabolism is rewired and regulated during the lytic cycle and stage differentiation. 
In specifics, this work aimed to investigate: 
 
Ø Central carbon metabolism of Toxoplasma and Plasmodium 
Ø Mechanisms of membrane biogenesis in Toxoplasma and Eimeria 
Ø Host metabolism as a determinant of the parasite infection (Eimeria and Toxoplasma) 
Ø Regulation of asexual reproduction in Toxoplasma  
Ø Potential anti-parasitic drug targets in the parasite metabolism 
 
The following sections describe and discuss the results generated using T. gondii, P. berghei and E. 
falciformis as the representative intracellular parasites. Collectively, these parasites have enabled a 
complementary study on discrete infectious stages of the apicomplexan lifecycle, e.g., tachyzoite, 
bradyzoite, sporozoite and merozoite (Fig 3). While T. gondii has been pivotal in this work owing 
to relative ease of culture and genetic tractability, P. berghei and E. falciformis have been imperative 




2 RESULTS AND DISCUSSION 
2.1  Central carbon metabolism of Toxoplasma gondii and Plasmodium berghei 
 
Underlying publications/manuscript (for abstracts, please refer to Section 5 on page 53-57): 
 
Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are 
dispensable by glutaminolysis. Blume M, Contreras DR, Landfear S, Fleige T, Soldati DF, Lucius R, 
Gupta N; Proceedings of National Academy of Sciences USA, 2009, 106(31): 12998-3003 Appendix A [84] 
 
A constitutive pan-hexose permease in Plasmodium and models for high-throughput screening of anti-
malarial sugar analogs. Blume M, Hliscs M, Contreras DR, Sanchez M, Landfear S, Lucius R, 
Matuschewski K, Gupta N; FASEB J, 2011, 25(4): 1218-29   Appendix B [85] 
 
Metabolic cooperation of glucose and glutamine is essential for the lytic cycle of obligate intracellular 
parasite Toxoplasma gondii. Nitzsche R, Zagoriy V, Lucius R, Gupta N; Journal of Biological Chemistry, 2016, 
291(1): 126-41          Appendix C [86]  
 
A Toxoplasma gondii gluconeogenic enzyme contributes to robust central carbon metabolism and is essential 
for replication and virulence. Blume M, Nitzsche R, Sternberg U, Gerlic M, Masters SL, Gupta N, 
McConville MJ; Cell Host & Microbe, 2015, 18(2): 210-20    Appendix D [87] 
 
A mitochondrial phosphoenolpyruvate carboxykinase ensures glucose-independent survival of the 
protozoan parasite Toxoplasma gondii. Nitzsche R, Tischer M, Zagoriy V, Gupta N Appendix E [submitted]  
 
Toxoplasma and Plasmodium are long known to be voracious consumers of glucose [88,89]. Sugar 
catabolism through glycolysis does not yield significant CO2 by feeding of sugar-derived pyruvate 
in the parasite mitochondrion; instead, it is reduced to lactate, which is excreted in cultures. This 
results in a lower energy yield (4 moles of ATP per mole of glucose as opposed to 36 moles when 
completely oxidized in the mitochondria) and loss of 3 carbons as lactate [90]. The phenomenon 
has been attributed to hypoxic intracellular environment these parasites are regularly faced with, 
although the quintessence of such an inefficient metabolism is quite intriguing. In other words, 
the scope and extent to which glucose satisfies the bioenergetic obligations in these parasites has 
not been adequately understood. We studied how sugar is imported and utilized for biosynthetic 
purpose, and whether parasites can deploy alternative sources of carbon. 
 
We identified closely related orthologs of facilitative sugar transporter in the genomes of T. gondii 
(TgGT1), P. berghei (PbHT1) and P. falciparum (PfHT1) (Appendix A-B). All three transporters exhibit 
similar substrate specificities. They can transport glucose, fructose, mannose as well as galactose, 
albeit with somewhat varying affinities. Surprisingly, genetic ablation of TgGT1 inflicted only a 
minor 30% defect in the tachyzoite growth, even though sugar import by the parasite was nearly 
abolished. Virulence of the Δtggt1 mutant in mice remained unaffected, indicating dispensability 
of glucose transport for in vivo reproduction of tachyzoites. The ATP-dependent gliding motility 
and de novo synthesis of RNA and proteins in the Δtggt1 mutant in standard culture medium were 
remarkably normal, which implied flexible usage of alternative nutrients. Indeed, we identified 




glutamine through the TCA cycle in a constitutive manner regardless of glycolytic flux. The 
Δtggt1 mutant shows induction of glutaminolysis along with activation of gluconeogenesis, which 



















Fig 9: Central carbon metabolism in the tachyzoite stage of T. gondii. The model is constructed based on our work, 
literature and annotations of selected enzymes expressed in the tachyzoite stage (www.ToxoDB.org). Only 
those metabolites relevant to this work are shown for simplicity. Glucose and glutamine are co-utilized to 
satisfy the carbon demands for biomass (protein, nucleotides, lipids), energy and reducing equivalents (not 
depicted). Parasites can also deploy acetate as a carbon source for lipid synthesis when available in culture. 
Lipid synthesis utilizes acetyl-CoA and 3PG (3-phosphoglycerate), which are mostly derived from glucose. 
Biogenesis of nucleotides requires ribose 5-phosphate produced by diversion of G6P (glucose-6 phosphate) 
to the pentose phosphate shunt. Likewise, protein synthesis uses glucose-derived nonessential amino acids, 
such as serine and glycine (not shown). Glutamine catabolism enables effective biosynthetic utilization of 
sugar-derived carbon by replenishing the TCA cycle (drained by macromolecule biogenesis in replicating 
parasites). Glutamine also confers the much-needed nitrogen pool for nucleotides and protein syntheses. 
Glutamine-derived carbon flux (TCA cycle and gluconeogenesis) can sustain the parasite survival without 
a severe growth defect, when glycolysis is compromised in tachyzoites. Other nutrients utilized by the 
parasite for membrane biogenesis include choline, ethanolamine, serine, inositol and threonine. Carbon 
metabolism is rewired to meet proliferating (intracellular) and non-proliferating (extracellular) demands as 
well as in response to the available nutrients. ACS, acetyl-CoA synthetase; ETC, electron transport chain; 































































Extracellular tachyzoites depend on either glucose or glutamine to invade host cells, because the 
exogenous milieu lacks any substitutive nutrients that can generate adequate energy to facilitate 
the gliding motility and host-cell invasion. Indeed, a pharmacological inhibition of glutaminolysis 
or oxidative phosphorylation in the glycolysis-deficient mutant arrests the lytic cycle. Intracellular 
parasites on the other hand show a much greater resilience, possibly by exploiting intermediates 
of the host-cell glycolysis and other amino acids. Nonetheless, glucose and glutamine are the two 
key physiologically important nutrients utilized for the synthesis of macromolecules (ATP, nucleic 
acid, proteins, lipids). They together furnish a major fraction of total biomass carbon and energy 
in a co-regulated manner, and either of them is sufficient to support the replication of tachyzoites 
(Appendix C). Ironically, whereas glutamine is capable of driving nucleotide and protein biogenesis 
when glycolysis is impaired, it falls short in ensuring an optimal fatty acid synthesis, which results 
in a wide-spectrum deficit of lipids leading to a modest growth defect in the Δtggt1 mutant. Lipid 
synthesis as well as the lytic cycle of the glycolytic mutant can be restored by acetate supplement, 
which can recompense for the glucose-derived acetyl-CoA for fatty acid synthesis and elongation 
via FASII and FAE pathways in the apicoplast and ER (Fig 9). Such a cooperative metabolism of 
glucose, glutamine and acetate in tachyzoites resembles the physiology of tumor cells [72,90–92]. 
 
Our ensuing work on gluconeogenesis has identified two isoforms of the gluconeogenic enzyme 
fructose 1,6-bisphosphatase (TgFBP1, TgFBP2) in tachyzoites, which are constitutively expressed 
(Appendix D). It is quite unusual given that expression of gluconeogenic enzymes is repressed when 
glucose is available to avert a futile cycling of glycolytic metabolites. We found that whereas 
TgFBP1 is dispensable irrespective of glucose catabolism, TgFBP2 is essential for the parasite 
survival even when glycolysis is intact. Conditional knockdown of TgFBP2 results in a complete 
cessation of the parasite growth and virulence in a mouse model. TgFBP2 deficiency translates 
into altered glycolytic and TCA cycle flux, as well as dysregulation of glycolipid, amylopectin and 
fatty acid syntheses. We therefore postulate a futile cycle between fructose 1,6-bisphosphatase 
(gluconeogenic) and phosphofructokinase (glycolytic) enzymes as a novel regulatory mechanism 
that may allow tachyzoites to rapidly adapt to nutrients available in different host cells. Our work 
also found two isoforms of phosphoenolpyruvate carboxykinase (PEPCK) protein, only one of 
which is expressed in the tachyzoite stage (PEPCKmt localized in the mitochondrion; Appendix E). 
Parasites tolerated the deletion of either isoforms, indicating a nonessential role of PEPCK 
enzymes in normal glucose-replete cultures. They could not survive collective ablations of both 
PEPCKmt and TgGT1 however, because the mitochondrial isoform is required for glutamine-
fueled gluconeogenesis, which in turn sustains the biomass production in proliferating parasites 
upon glycolytic dysfunction. Once again, these results on PEPCKmt-dependent gluconeogenesis 
converge with cancer cells, which rely on glutamine-derived carbon flux to withstand glucose-
independent growth [93]. 
 
We also observed that the physiological significance of glucose for Plasmodium contrasts with T. 
gondii, even though the former can also assimilate glutamine as a major carbon source [94]. It was 




which confirms an essential role of glucose for erythrocytic stages of P. berghei (Appendix B). These 
results on genetic essentiality of glycolysis have also been independently confirmed by a similar 
study on P. falciparum and P. berghei [95]. Our in silico searches show that both Plasmodium species 
lack gluconeogenesis, which renders glycolysis essential. Unlike glycolysis, most of the enzymes of 
TCA cycle have been shown to be nonessential for the asexual growth of P. falciparum [96]. These 
mitochondrial mutants exhibited a normal erythrocytic cycle; however, their development was 
severely interrupted in the mosquito host. Along the line, we determined that a glucose analog 
(C3361) potently inhibits the sexual and hepatic development of P. berghei. Therefore, it can be 
concluded that glucose is indispensable for the entire lifecycle of Plasmodium species. To pursue a 
translational application of these findings, we generated transgenic strains of Saccharomyces cerevisiae 
and P. berghei, which express hexose transporter of P. falciparum in lieu of endogenous permease(s), 
and as a consequence depend on PfHT1 for their survival. These two models together permit a 
streamlined in vitro prescreening and subsequent in vivo assessment of antimalarial sugar analogs. 




2.2  Phospholipid biogenesis in tachyzoites of Toxoplasma gondii 
Intracellular proliferation of tachyzoites and expansion of the PV require substantial synthesis of 
organelle membranes, which are composed of predominantly neutral and polar lipids. This work 
explored several primary features of phospholipid metabolism in T. gondii. We demonstrate that 
tachyzoites harbor standard eukaryotic as well as atypical lipids. Phosphatidylcholine (PtdCho) is 
the most common lipid, followed by phosphatidylethanolamine (PtdEtn), phosphatidylthreonine 
(PtdThr), phosphatidylinositol (PtdIns), phosphatidylserine (PtdSer), ethanolamine-
phosphorylceramide (EPC), phosphatidylglycerol (PtdGro) and phosphatidate (PtdOH) (Fig 10). 
Intracellular tachyzoites express a nearly complete set of enzymes, which catalyze the synthesis of 
































Fig 10: Pathways of phospholipid syntheses in the tachyzoite stages of T. gondii. The model is constructed primarily 
based on our results. Lipid precursors are shown in blue; the intermediates of lipid synthesis are in black; 
and phospholipids are in red. Phospholipid synthesis begins with the synthesis of precursor lipid (PtdOH), 
which is converted to diacylglycerol (DAG) for making PtdCho and PtdEtn in the ER. PtdEtn can also be 
generated in the mitochondrion and PV by decarboxylation of PtdSer. Unlike mammalian cells, PtdEtn is 
not methylated to make PtdCho (red cross). PtdThr and PtdSer are produced exclusively in the parasite 
ER. PtdOH in the ER and apicoplast also yields CDP-DAG, which serves as a substrate for the synthesis 
of PtdIns in the Golgi bodies and PtdGro in the mitochondrion. Glycerol backbone and fatty acids are 
originally derived from glycolysis (Fig 9). Phospholipid synthesis is significantly induced or repressed when 




Synthesis of phospholipids is intimately interconnected, which occurs mainly in the endoplasmic 
reticulum, mitochondrion, Golgi bodies, apicoplast and PV (Fig 10). Our studies demonstrate the 
existence of the CDP-choline and CDP-ethanolamine pathways to generate PtdCho and PtdEtn, 
respectively. Their syntheses involve PtdOH-derived DAG and CDP-conjugated intermediates of 
choline or ethanolamine. Tachyzoites can also decarboxylate PtdSer to synthesize PtdEtn. In 
converse, PtdSer is made from PtdEtn by substituting the head groups (ethanolamine by serine). 
A similar base-exchange pathway exists for producing PtdThr, possibly utilizing PtdCho as a 
donor lipid (substitution of choline by threonine). Unlike others, synthesis of PtdIns and PtdGro 
utilizes CDP-DAG as a precursor instead of DAG. Highly compartmentalized syntheses of most 
lipid precursors suggest substantial inter-organelle trafficking. Following text describes biogenesis 
and biological relevance of major phospholipids during the lytic cycle of tachyzoites. 
 
2.2.1 Phosphatidylcholine synthesis – an anti-parasitic drug target 
 
Underlying publications (for abstracts, please refer to Section 5 on page 58-59): 
 
Selective disruption of phosphatidylcholine metabolism of the intracellular parasite Toxoplasma gondii 
arrests its growth. Gupta N, Zahn MM, Coppens I, Joiner KA, Voelker DR; Journal of Biological Chemistry, 
2005, 280(16): 16345–53       Appendix F [97] 
 
Conditional mutagenesis of a novel choline kinase demonstrates the plasticity of phosphatidylcholine 
biogenesis and gene expression in Toxoplasma gondii. Sampels V, Hartmann A, Dietrich I, Coppens I, 
Sheiner L, Striepen B, Herrmann A, Lucius R, Gupta N; Journal of Biological Chemistry, 2012, 287(20): 
16289-99         Appendix G [98] 
 
PtdCho is the most abundant lipid in the tachyzoite membranes. It amounts up to 75% of total 
phospholipids (Appendix F). Our results provide important insights into PtdCho synthesis of T. 
gondii. Similar to mammalian cells [99], tachyzoites express the three-step CDP-choline pathway 
to synthesize PtdCho using choline and DAG (Fig 11). They however lack the enzyme activity for 
PtdEtn methyltransferase and therefore unable to make PtdCho by methylating PtdEtn (Fig 10). 
Unlike Plasmodium [100,101], tachyzoites are also unable to produce PtdCho using serine and 
ethanolamine as precursors because they do not harbor the plant-type serine decarboxylase and 
phosphoethanolamine methyltransferase enzymes, respectively. Interception of host’s low-density 
lipoproteins containing PtdCho offers an alternative route to acquire PtdCho. Our assays using 
LDL particles loaded with a fluorescent lipid probe did not reveal a marked import of PtdCho by 
intracellular tachyzoites [102]. Likewise, metabolic labeling of host-free parasites with fluorescent 
PtdCho did not show any noteworthy uptake. As a consequence, tachyzoites depend on their de 
novo CDP-choline pathway to produce majority of PtdCho. 
 
The dependence of T. gondii on choline for PtdCho synthesis renders its CDP-choline pathway 
vulnerable to pharmacological inhibition by choline analogs. We assessed dimethylethanolamine 




in a rather selective manner (Appendix F). The host-cell lysis was greatly reduced and the parasite 
yield was declined by almost 3 orders of magnitude when treated with DME. Parasites cultured 
with permissible amounts of DME accumulated high level of phosphatidyldimethylethanolamine 
(PDME, a PtdCho analog), which was inversely correlated with the content of PtdCho. Electron 
microscopy revealed that DME dramatically altered the membrane organization in developing 
parasites. The newly forming progeny were most profoundly affected, because they seem unable 
to obtain sufficient PtdCho from host cells, which could thwart the DME-mediated inhibition of 
de novo PtdCho synthesis (Fig 11). Anti-parasitic effect of DME appears to be a result of accrued 
































Fig 11: Current model of PtdCho biogenesis in T. gondii tachyzoites. The parasite seems to be a choline auxotroph 
for making PtdCho via the three-step CDP-choline pathway localized in three different organelles. The 
first enzyme CK is cytosolic, the second and rate-limiting enzyme CCT is nuclear, and the last one (CPT) 
catalyzing the synthesis of PtdCho using CDP-choline and DAG is located in the ER. Unlike Plasmodium, 
scavenging of host PtdCho (LDL-derived or via host ER-PVM association) likely does not contribute to 
PtdCho biogenesis. Host CCT (HsCCT) is upregulated in infected human fibroblasts, but its functional 
relevance is unclear. Dotted arrows denote transport processes. Image is redrawn from the PhD thesis of 
Vera Sampels [102]. CK, choline kinase; CCT, CTP-phosphocholine cytidylyltransferase; CPT, choline 




In follow-up work, we showed that the synthesis of PtdCho is initiated by a novel choline kinase 
(TgCK), which forms oligomers in the tachyzoite cytosol (Appendix G). The corresponding gene 
could not be directly deleted, indicating an essential nature of choline kinase activity. Conditional 
mutagenesis of the TgCK gene by promoter displacement in tachyzoites attenuated the protein 
level. The activity could not be eliminated however, which led to the unexpected identification of 
two additional shorter isoforms encoded by a cryptic promoter. We also observed a quantitative 
concordance between the enzyme activity and PtdCho synthesis, which entails a dependence of 
parasites on de novo CDP-choline route. The conditional mutant displayed a surprisingly normal 
off-state growth despite a 35% decline in total PtdCho content. The data reveal a compositional 
flexibility in the tachyzoite membranes while advocating against the salvage of host PtdCho in 
sufficient amounts to hedge a knockdown of the CDP-choline pathway. Meanwhile, we have also 
generated a conditional mutant of the second enzyme (CCT), which exhibits 50% impairment in 
growth when its expression is turned off [102]. Future work involves creating and phenotyping 
the mutants of CPT, the last enzyme of PtdCho synthesis located in the ER (Fig 11). 
 
2.2.2 Plasticity of phosphatidylethanolamine biogenesis 
 
Underlying publications (for abstracts, please refer to Section 5 on page 60-61): 
 
The obligate intracellular parasite Toxoplasma gondii secretes a soluble phosphatidylserine decarboxylase. 
Gupta N, Hartmann A, Lucius R, Voelker DR; Journal of Biological Chemistry, 2012, 287(27): 22938-47 
          Appendix H [103] 
 
Phosphatidylethanolamine synthesis in the parasite mitochondrion is required for efficient growth but 
dispensable for survival of Toxoplasma gondii. Hartmann A, Hellmund M, Lucius R, Voelker DR, Gupta N; 
Journal of Biological Chemistry, 2014, 289(10): 6809-24    Appendix I [104] 
 
PtdEtn is the second most abundant phospholipid in T. gondii tachyzoites, accounting for 15-20% 
of total phospholipids. Parasites can synthesize PtdEtn in the mitochondrion and parasitophorous 
vacuole by PtdSer decarboxylation as well as in the ER through the CDP-ethanolamine pathway 
(Appendix H-I). Two different PtdSer decarboxylase enzymes, TgPSD1mt and TgPSD1pv localized 
in the mitochondrion and PV respectively, are expressed in tachyzoites (Fig 12). Genetic ablation 
of TgPSD1mt expression caused ≈45% impairment in the mutant’s growth. Unexpectedly, no 
obvious change in the total PtdEtn content of the mutant was observed, signifying the activation 
of compensatory routes. Indeed, metabolic labeling with ethanolamine revealed induction of the 
CDP-ethanolamine pathway in the ER when TgPSD1mt was repressed. Consistently, depletion of 
ethanolamine intensified the growth defect in the TgPSD1mt mutant, which could be partially 
rescued by add-back assay. Hence, both routes are not mutually exclusive and specific exchange 
of lipid seems to exist between the mitochondrion and ER of tachyzoites. Such a phenomenon 
has already been reported to occur in mammalian cells [99,105]. The presence of lipid trafficking 




Our work also revealed that tachyzoites secrete a soluble form of PtdSer decarboxylase to the PV 
via dense granules. Unlike other PSDs, which require detergent-solubilized substrate, TgPSD1pv 
can decarboxylate even the liposomal PtdSer with a high affinity (Km, 67 μM). It is a novel protein 
because a secreted, soluble and interfacially active PSD has not been previously described from 
any organism. Remarkably, tachyzoites can survive genetic deletion of TgPSD1pv with no evident 
defect in growth and lipid composition, which is probably due to acquisition of PtdEtn from host 
cells [106] (Fig 12). In this regard, a close association of the PVM with the host mitochondria and 
ER might serve as the privileged sites of lipid exchange. Our initial work found that the parasite 
genome encodes at least four P4-ATPase-type permeases, which may facilitate transport of host-
derived lipids to the parasite body. Such a resourceful PtdEtn synthesis bestows a considerable 


























Fig 12: Multiple routes of PtdEtn biogenesis in T. gondii tachyzoites. Three distinct pathways operate for making 
PtdEtn in different organelles. The mitochondrial and secretory variants of PtdSer decarboxylase (PSD) 
generate PtdEtn by decarboxylating PtdSer in the mitochondrion and PV (and maybe in dense granules). 
PtdEtn synthesis via the CDP-ethanolamine pathway occurs in the ER. The parasite may also acquire 
PtdEtn from the host ER and/or mitochondria (associated with PVM). Tachyzoites also encode at least 4 
putative lipids transporters (P4-ATPase type), whose locations, functions and relevance are not known. In 
short, multiple sites of PtdEtn biogenesis collaborate to realize a robust membrane biogenesis, and thereby 
ensure the parasite survival upon nutritional perturbations. Image is adapted from the PhD dissertation of 
Anne Hartmann [106]. DG, dense granule; EK, ethanolamine kinase; ECT, CTP-phosphoethanolamine 




2.2.3 Functional speciation of phosphatidylserine and phosphatidylthreonine 
 
Underlying publications (for abstracts, please refer to Section 5 on page 62-63): 
 
Phosphatidylthreonine and lipid-mediated control parasite virulence. Arroyo-Olarte RD, Brouwers JF, 
Kuchipudi A, Helms JB, Biswas A, Dunay IR, Lucius R, Gupta N; PLoS Biology, 2015, 13(11):  e1002288 
          Appendix J [107] 
 
Optogenetic monitoring identifies phosphatidylthreonine-regulated calcium homeostasis in Toxoplasma 
gondii. Kuchipudi A, Arroyo-Olarte RD, Hoffmann F, Brinkmann V, Gupta N; Microbial Cell, 2016, 3(5): 
215-23          Appendix K [108] 
 
Phosphatidylthreonine: An exclusive phospholipid regulating calcium homeostasis and virulence in a 
parasitic protist. Arroyo-Olarte RD and Gupta N; Microbial Cell, 2016, 3(5): 189-190 (micro-review)         
          Appendix L [109]	  
	  
Most organisms across the tree of life use a limited repertoire of phospholipids [105]. This study 
demonstrates the natural expression and genetic origin of an exclusive lipid PtdThr that is in fact 
the third most abundant phospholipid in tachyzoites (5-10%) (Appendix J). PtdThr is related to 
PtdSer, a near-universal lipid present only as a minor phospholipid in the tachyzoite membranes 
(2-3%). Our work identified two closely related enzymes TgPTS (PtdThr synthase) and TgPSS 
(PtdSer synthase), located in the parasite ER, where they perform the synthesis of PtdThr and 
PtdSer, respectively. Both enzymes utilize PtdEtn and/or PtdCho as the donor lipids to catalyze 
the base-exchange reaction (substitution of ethanolamine in PtdEtn or of choline in PtdCho by 
serine or threonine). Unlike TgPSS, orthologs of TgPTS could only be found in selected parasitic 
(Neospora, Eimeria, Phytophtora) and free-living (Perkinsus) chromalveolates. The TgPSS gene could 
not be deleted in tachyzoites, indicating an essential role of PtdSer for the lytic cycle. Parasites 
did survive disruption of the TgPTS gene, though the mutant showed severely compromised lytic 
cycle and virulence (Fig 13). Surprisingly, the Δtgpts strain did not exhibit impaired replication; 
instead, the phenotype was caused by a reduced gliding motility, which blighted the downstream 
events of parasite egress and host-cell invasion. The PTS mutant can prevent toxoplasmosis in a 
mouse model, which endorses its potential clinical utility as a metabolically attenuated vaccine. 
 
The PTS mutant lacking PtdThr showed a proportionate increment in PtdSer, which is reversed 
by genetic complementation (Appendix J). In line, we observed an apparent increase in the level of 
another anionic lipid, PtdIns; however only when PtdSer content was restored to a normal level 
in a conditional double mutant of TgPSS and TgPTS. Such a reversible and proportionate 
balancing of the three anionic lipids in tachyzoites appears to maintain the parasite replication, 
but certainly unable to uphold the virulence of the Δtgpts mutant. It is therefore plausible that the 
parasite has evolved PtdThr to optimize its lytic cycle, while satisfying the customary roles of 
anionic phospholipids in membrane biogenesis. In conjunction with aforesaid text (Section 2.2.1 
and 2.2.2), these data also reinforce a compositional flexibility in the parasite membranes, which 




In succeeding work, using our newly adapted method based on a gene-encoded calcium indicator 
GCaMP6s, we showed that the loss of PtdThr depletes calcium stores in intracellular tachyzoites, 
which leads to dysregulation of cytosolic calcium and accordingly impairs the gliding motility and 
egress (Appendix K-L). Consistently, the parasite motility as well as egress can be entirely restored 
by ionophore-induced mobilization of calcium in the mutant. Collectively, these results suggest a 
novel regulatory function of PtdThr in calcium signaling of a prevalent parasitic protist, as well as 
indicate adaptive and functional speciation of PtdThr from an otherwise-conserved lipid PtdSer. 
Notably, the parasite also harbors a plant-like pathway to make threonine, an amino acid that is 
essential for mammalian cells. It therefore appears as though serine-threonine homeostasis in T. 
gondii is quite distinct from its host. Our work has already identified 4 out of 5 enzymes of de novo 
threonine synthesis, which provide a strong basis for future research on the mechanism, evolution 

























Fig 13: PtdThr-mediated control of lytic cycle and virulence in T. gondii. The parental tachyzoites express a PtdThr 
synthase (PTS). A disruption of the PTS gene results in parasites that are unable to make PtdThr, which 
compromises the sequential events of calcium discharge in the parasite cytosol, gliding motility, egress 
from parasitized cells and entry into new host cells. As a consequence, the PTS mutant displays a severely 
impaired lytic cycle in human cells and attenuated virulence in a mouse model. The mutant can confer 




2.2.4 Biogenesis of phosphatidylinositol and phosphatidylglycerol 
 
Underlying manuscript (for abstract, please refer to Section 5 on page 64): 
 
Two distinct CDP-diacylglycerol synthases in the parasite ER and apicoplast cooperate to ensure lipid 
biogenesis in Toxoplasma gondii. Kong P, Ufermann CM, Yin Q, Suo X, Helms JB, Brouwers JF, Gupta N 
         Appendix M [submitted] 
 
Phospholipid synthesis begins with the conversion of PtdOH into precursor lipids, DAG or CDP-
DAG. The latter serves as a precursor for the synthesis of PtdCho and PtdEtn, while CDP-DAG 
is utilized to synthesize PtdIns and PtdGro (Fig 10). We identified two phylogenetically divergent 
CDP-DAG synthases in tachyzoites (Appendix M), of which the eukaryotic-type TgCDS1 is located 
in the ER, and prokaryotic-type TgCDS2 in the apicoplast. Conditional mutagenesis of TgCDS1 
severely attenuated the parasite growth, which was abolished by subsequent deletion of TgCDS2. 
The conditional mutant of TgCDS1 was dramatically compromised in its virulence in the mouse. 
Moreover, animals surviving infection with the mutant became immunized to challenge infection 
with the hypervirulent strain of T. gondii. The mutants revealed significantly reduced PtdIns level 
upon chemical repression of TgCDS1, even though total phospholipids were markedly increased. 
On the other hand, the ablation of TgCDS2 (but not of TgCDS1) led to an evident decrease in 
PtdGro without perturbing PtdIns. In other words, the two enzymes are required for producing 
different lipids, namely PtdIns and PtdGro, indicating their complementary roles in membrane 
biogenesis. Our work also suggests that the host is unable to meet the requirement of CDP-DAG 
when its synthesis within the parasite is compromised. Physiological essentiality and phylogenetic 
divergence of CDP-DAG synthesis route offer an opportunity to selectively inhibit the parasite. 
 
Our succeeding work has revealed the autonomous syntheses of PtdIns and PtdGro in T. gondii, 
which occurs in Golgi bodies and mitochondrion, respectively. Taken together, the data show a 
‘division of labor’ model of lipid biogenesis, in which two separate pools of CDP-DAG originating 
in the ER and apicoplast are utilized to synthesize PtdIns in the Golgi bodies and PtdGro in the 
mitochondrion (Fig 14). A knockout mutant of one of the underlying enzymes, PtdIns synthase 
(PIS), could not be generated, signifying its essential nature. Making of a workable conditional 
mutant was also not feasible, as the transgenic parasites did not allow an adequate repression of 
the enzyme activity. Eventually, we were successful in destabilizing PIS transcript by Cre-LoxP- 
mediated excision of 3’UTR, which considerably attenuated the tachyzoite growth in nascent 
cultures. However the mutant strains adapted rapidly following few passages, which prevented 
biochemical phenotyping of the mutant. Nonetheless, the results do indicate that parasites are 
not competent in scavenging host-derived PtdIns in sufficient amounts to bypass a disruption of 
its endogenous lipid synthesis. We are currently using alternative approaches (dominant negative, 
CRISPR/Cas9) to obtain a stable mutant to assess the functional importance of PtdIns. Similar 





























Fig 14: Synthesis of PtdIns and PtdGro in the tachyzoite stage of T. gondii. PtdOH serves as a precursor for CDP-
DAG, providing the phospholipid backbone. Catalysis of PtdOH into CDP-DAG is executed by TgCDS1 
in the ER and by TgCDS2 in the apicoplast. TgCDS1-derived CDP-DAG is used to make PtdIns in the 
Golgi body (and maybe PtdSer in the ER), while CDP-DAG originating from TgCDS2 facilitates PtdGro 
and cardiolipin syntheses in the mitochondrion. FASII performs de novo synthesis of fatty acids (apicoplast) 
that are elongated in the ER. Identities of the gray-shaded enzymes (CDP-DAG-dependent PSSc, PGPP) 
are not known. Dotted arrows indicate inter-organelle transport of lipids. PtdIns is likely transported from 
Golgi to the ER for the synthesis of GPI anchors (not shown). CDS, CDP-DAG synthase; FASII, fatty 
acid synthase II; FAE, fatty acid elongase; PGPP, PtdGro-phosphate phosphatase; PGPS, PtdGro-




2.3 Phospholipid syntheses in sporozoites of Eimeria falciformis 
 
Underlying manuscript (for abstract, please refer to Section 5 on page 65): 
 
Expression of exclusive lipids and autonomous membrane biogenesis indicate a host-independent lifestyle 
of Eimeria sporozoites. Kong P, Brandt S, Brouwers JF, Helms JB, Lucius R, Gupta N   
          Appendix N [in prep.] 
 
The study of sporozoite stage metabolism is profoundly interesting because this is the only freely 
developing stage of apicomplexan parasites. It allows assessment of the ‘true’ metabolic potential 
of a parasite (independent of host cell), as well as offers alternative targets to block transmission. 
While Toxoplasma and Plasmodium species do enable a comprehensive dissection of apicomplexan 
biology, examining the sporozoite stage metabolism is practically challenging because oocysts are 
produced in a feline or mosquito host, respectively. Hence, we implemented E. falciformis, which 
completes its entire lifecycle in the rodent host and grants a decent model to study the sporozoite 
stage. Even though our sustained efforts to stably manipulate the E. falciformis genome have been 
futile, we have achieved a feasible transient expression system in sporozoites. In conjunction with 
the tachyzoite stage of T. gondii (a surrogate model), we have started exploring carbon metabolism 
and membrane biogenesis in Eimeria sporozoites. The following results show our advanced-stage 
work on phospholipid syntheses in the sporozoite stage of E. falciformis (Appendix N). 
 
In-depth lipidomics analyses of sporozoites purified from the sporulated oocysts revealed that the 
membrane composition of Eimeria sporozoites is similar to that of T. gondii tachyzoites excluding 
few exceptions. PtdCho (79%) and PtdEtn (13%) are the two most abundant lipids accounting for 
more than 90% of total phospholipids in Eimeria. Sporozoites also express PtdThr (6%), a rare 
lipid shared by tachyzoites, but absent in most organisms including the mouse host. Interestingly, 
PtdIns in sporozoites is not as abundant as in tachyzoites (1.5% vs. 5%), and PtdSer makes up 
only a rather minor (0.5%) lipid fraction. In contrast to tachyzoites, which express ethanolamine-
phosphorylceramide instead of sphingomyelin, sporozoites harbor inositol-phosphorylceramide 
(IPC). There is no evidence for the natural expression of EPC and IPC in mammalian cells, but 
they have been reported to occur in kinetoplastid parasites [110].  
 
Most of the core enzymes of lipid synthesis are expressed in the sporozoite stage of E. falciformis, 
indicating its autonomous membrane biogenesis (Fig 15). Our immunofluorescence localization 
studies in T. gondii tachyzoites and E. falciformis sporozoites show that the latter stage harbors two 
distinct CDP-DAG synthases in the ER and apicoplast, and a PtdIns synthase to make PtdIns in 
the Golgi bodies. In addition, they express the CDP-choline and CDP-ethanolamine pathways in 
the ER to synthesize PtdCho and PtdEtn respectively, and a second mitochondrial route to make 
PtdEtn by decarboxylation of PtdSer. Two discrete PSD proteins are expressed in the parasite 
mitochondrion and dense granules (secreted into the PV after invasion of host cells). As observed 




PtdGro and cardiolipin are generated in the parasite mitochondrion. Unlike Plasmodium but akin 
to T. gondii, Eimeria lacks the serine decarboxylase and phosphoethanolamine N-methyltransferase 



























Fig 15: Syntheses of phospholipids in the sporozoite stage of E. falciformis. PtdCho, PtdEtn, PtdThr and PtdIns are 
the major phospholipids present in sporozoites. PtdSer, PtdGro and PtdOH account for minor fractions. 
Synthesis of most lipids is inter-linked and appears to be somewhat redundant due to multiple isoforms of 
a given enzyme (see numbers in image) or due to more than one ways of synthesis (e.g., PtdEtn). The gray 
arrows denote an unclear mode of base-exchange reaction; for instance, PtdSer and PtdThr may be made 
in a converse manner from PtdCho and PtdEtn, respectively. Identity of PGPP (gray oval) is not clear. 
CDS, CDP-DAG synthase; CLS, cardiolipin synthase; CEPT, choline-ethanolamine phosphotransferase; 
DGK, diacylglycerol kinase; PAP, PtdOH phosphatase; PGPP, PtdGro-phosphate phosphatase; PGPS, 
PtdGro-phosphate synthase; PIS, PtdIns synthase; PSD, PtdSer decarboxylase; PSS, PtdSer synthase; 
PTS, PtdThr synthase 
 
We were able to confirm the functions of EfPIS and EfPTS, so far. EfPIS was overexpressed in E. 
coli, which lacks the natural synthesis of PtdIns. Recombinant bacteria expressing EfPIS exhibited 
inositol-dependent synthesis of PtdIns. Equally, EfPTS could rescue the lytic cycle of a tachyzoite 
mutant with disrupted PtdThr synthesis. Even though many enzymes are still to be functionally 
characterized, our groundwork on lipid biogenesis and gene manipulation of sporozoites provides 




2.4 Host determinants of coccidian development 
 
Underlying publications/manuscript (for abstracts, please refer to Section 5 on page 66-68): 
 
Eimeria falciformis infection of the mouse caecum identifies opposing roles of IFNγ-regulated host pathways 
for the parasite development. Schmid M, Heitlinger E, Spork S, Mollenkopf HP, Lucius R, Gupta N; 
Mucosal Immunology, 2014, 7(4): 969-82      Appendix O [111] 
 
Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in 
the mouse. Schmid M, Lehmann MJ, Lucius R, Gupta N; Journal of Biological Chemistry, 2012, 287(24): 
20197-207         Appendix P [112] 
 
Apicomplexan parasites, Toxoplasma gondii and Eimeria falciformis, induce and co-opt a master transcription 
factor cFos in mammalian host cell. Ren B, Schmid M, Mollenkopf HP, Heitlinger E, Gupta N  
          Appendix Q [in prep.] 
 
Previous sections describe metabolic potential of selected apicomplexan parasites and its impact 
on the asexual development, pathogenesis and adaptation. To ascertain the design principles of 
intracellular parasitism, it is equally imperative to investigate how these parasites exploit host cells 
for their survival and reproduction. At the outset, we employed E. falciformis infection of mouse to 
deduce the modulation of host transcriptome using microarray technology (Appendix O). Our gene 
expression analyses of the parasitized caeca samples (enriched in epithelial cells) identified a 
retinue of host proteins modulated by the parasite. Most prominent mouse genes induced during 
the onset of asexual and sexual development of Eimeria comprise interferon γ (IFNγ)-regulated 
factors, e.g., several enzymes of the kynurenine pathway including indoleamine 2,3-dioxygenase 1 
(IDO1), immunity-related GTPases, guanylate-binding proteins and chemokines (Fig 16). In 
addition, we found significant perturbation of TLR, MAPK and JAK-STAT-mediated signaling 
cascades. Based on these results, we were able to discern many hypotheses, some of which have 
already been validated. 
 
Of note is the induction of tryptophan degradation via the kynurenine pathway, which is usually 
deemed as one of the innate host immune responses to deprive and kill pathogens like T. gondii, 
because they are unable to produce tryptophan and depend on the host cell to supply this vital 
nutrient [113,114]. Contrary to the reported anti-parasitic function, we observed that inhibition 
of the rate-limiting enzyme of the kynurenine pathway (IDO1) by pharmacological and genetic 
means impairs the oocyst output, revealing an unforeseen supportive role of IDO1-mediated 
tryptophan catabolism in vivo (Appendix O-P). Indeed, we found that a byproduct of the kynurenine 
pathway, xanthurenic acid, can entirely reinstate the oocyst output in mice with impaired amino 
acid degradation. Xanthurenic acid is generally used as a gametocyte-activating factor in cultures 
of Plasmodium species [115–117]. It is presumed to foster the sexual development of Plasmodium by 
promoting exflagellation of the male gametes in mosquitoes. A similar role in gametogenesis of E. 
falciformis is also expected. Exploitation of host tryptophan catabolism by both parasites therefore 


















































Fig 16: Proposed model of Eimeria falciformis-mouse interactions. The model is based on our ex vivo microarray 
analyses of the parasite-infected mouse caecum cells (except for cFoS/FosB, which are induced in vitro). 
Only those host pathways for which transgenic animals are available are depicted. The color-coded (red 
or green) proteins were induced or repressed. The ‘+’ and ‘-’ signs in circles denote a positive or negative 
impact of a given pathway on the parasite development, as confirmed by validation assays. Note that we 
observed significant modulation of immune genes, which is due to the presence of immune cells in caeca 




Our results also demonstrate other IFNγ-regulated defense mechanisms in the Eimeria-infected 
mouse including several members of the IRG and GBP family (Appendix O). These proteins confer 
resistance to a variety of organisms in a mostly pathogen-specific manner [118]. The mechanism 
of their action has been extensively characterized during T. gondii infection [119–121]. Many 
members of the IRG and GBP family assemble at the PVM, and afterwards kill the susceptible 
parasite strains. The hypervirulent strains of T. gondii can inactivate IRG and GBP proteins and 
thereby prevent their recruitment onto the PVM [122,123]. Our work found that one of the key 
members of the IRG family, IRGB6, failed to coat the PVM of E. falciformis, implying either a 
lack of vacuolar propensity to bind IRG, or inactivation by the parasite. Determining the precise 
roles of highly induced IRG and GBP proteins during Eimeria infection warrants further research.  
 
In addition to the mentioned cell-intrinsic defense pathways, we observed the onset of adaptive 
immunity (Fig 16). The key chemokines, CxCL9-11, likely secreted by infected epithelial cells, 
were induced within 24  h of infection. Consistently, we saw significant increase in the chemokine-
directed recruitment of lymphocytes and macrophages to the Eimeria-infected caeca. Inhibition of 
CxCR3 (a common receptor for CxCL9-11 expressed on immune cells) in parasitized animals 
promoted the parasite development (Appendix O). These data suggest a critical role of epithelial 
chemokines in initiating the adaptive immune response and controlling the parasite infection. 
Although pending validation in transgenic mice, our findings resonate well with a role of CxCR3 
in orchestrating the innate and adaptive immune response against T. gondii tachyzoites [124]. 
 
To consolidate above ex vivo gene expression datasets, we executed transcriptomic analyses of the 
young adult mouse colon epithelial cells infected with E. falciformis or T. gondii. As expected, we 
detected a series of host defense pathways, such as TLR, MAPK and JAK-STAT signaling and 
cytokine-receptor interactions, majority of which are governed by IFNγ in response to infection 
regardless of the parasite in question. Surprisingly however, we observed distinct host response in 
many housekeeping pathways (mTOR, WNT, cAMP signaling), which implied that even related 
pathogens reprogram an otherwise-shared intracellular niche in a tailored manner (Appendix Q). 
Our analyses revealed only two genes (encoding cFos and Rab24 proteins) that were consistently 
induced by both parasites at early and late time points. Rab24 belongs to a small GTPase family 
possibly involved in autophagy, whereas cFos is a well-known master transcription factor (part of 
AP1 complex) and a proto-oncogene, which governs a repertoire of cellular processes, including 
but not limited to, proliferation, apoptosis, inflammation and oncogenesis. In-depth phenotyping 
of T. gondii cultures in mouse embryonic fibroblasts lacking cFos expression showed that the 
protein was indeed needed for an efficient intracellular replication. Plaque assays using the cFos-/- 
mutant cells confirmed an apparently essential function of cFos for the lytic cycle of T. gondii. 
Accordingly, the asexual development of E. falciformis was also significantly impaired in the cFos-
knockout host cells. Taken together, our ex vivo and in vitro gene expression analyses support a 
model with divergent roles of mouse proteins during infection, some of which defend the insult 




2.5 Regulation of asexual reproduction in Toxoplasma gondii 
 
Underlying publications (for abstracts, please refer to Section 5 on page 69-71): 
 
Dynein Light Chain 8a of Toxoplasma gondii, a unique conoid-localized β-strand-swapped homodimer, is 
required for an efficient parasite growth. Qureshi B, Hoffmann N, Arroyo-Olarte RD, Nickl B, Höhne W, 
Jungblut P, Lucius R, Scheerer P, Gupta N; FASEB J, 2013, 27(3): 1034-47 Appendix R [125] 
 
Optogenetic modulation of an adenylate cyclase in Toxoplasma gondii demonstrates a requirement of 
parasite cAMP for host-cell invasion and stage differentiation. Hartmann A, Arroyo-Olarte RD, Imkeller 
K, Hegemann P, Lucius R, Gupta N; Journal of Biological Chemistry, 2013, 288(19): 13705-17  
          Appendix S [126] 
 
Toxoplasma gondii cAMP-dependent protein kinase subunit 3 is involved in the switch from tachyzoite to 
bradyzoite development. Sugi T, Ma YF, Tomita T, Murakoshi F, Eaton MS, Yakubu R, Han B, Tu V, 
Kato K, Kawazu SI, Gupta N, Suvorova ES, White MW, Kim K, Weiss LM; mBio, 2016, 7(3): e00755-16 
          Appendix T [127] 
 
With a prospective aim to determine the core regulation of asexual reproduction in T. gondii, we 
have begun studying certain conserved proteins and pathways that are known to govern growth 
and maintenance by altering gene expression, metabolism, ion homeostasis, catalytic modulation, 
transport activity and protein-protein interactions. These include cNMP- and mTOR-mediated 
signaling and dyneins. It is noteworthy that Toxoplasma harbors one of the largest repertoires of 
dynein light chains (DLC). DLC8 is one such common eukaryotic protein, which controls diverse 
functions, most notably cargo transport and protein-protein interactions. We show that parasites 
harbor 4 DLC8 proteins (TgDLC8a-d), of which only TgDLC8a clusters in the archetypal DLC8 
class. TgDLC8b-d proteins form a divergent alveolate-specific clade (Appendix R). TgDLC8b-d 
proteins are mainly cytosolic, whereas TgDLC8a resides in the conoid region of T. gondii. Quite 
intriguingly, the apical location of TgDLC8a is not shared by its nearly identical orthologs from 
Plasmodium and Eimeria species. Unlike PfDLC8, but akin to HsDLC8, TgDLC8a exhibits a classic 
homodimeric structure with two identical binding grooves, which are designed for multi-target 
recognition (Fig 17). These results show a surprising structural-functional divergence of the two 
otherwise-conserved proteins from related parasites. 
 
One of the well-known functions of dyneins is the minus-end-directed retrograde cargo transport 
in mammalian cells [128]. Notably, the minus ends of the spiral and subpellicular microtubules 
in T. gondii are located in the conoid region, which implies a function of TgDLC8a in the minus-
end-directed transport of the protein cargo to the parasite apex, probably along the pair of intra-
conoid microtubules. This notion resonates with the apical presence of TgDLC8a in tachyzoites. 
Yet another elemental role of mammalian DLC8 is to promote dimerization/stabilization of the 
interacting partners and thereby regulate several subcellular events [129]. Indeed, we found that 
the dimerization of TgDLC8a is a prerequisite for efficient growth of tachyzoites. Further studies 




hypothetical proteins as putative interacting partners of TgDLC8a, which point to a central role 
of homodimer in regulating motor as well as non-motor processes. Our focus now is to define the 




















Fig 17: Comparison of TgDLC8a with HsDLC8 and PfDLC8 structures. Top row: The monomer-monomer 
crystal packing of HsDLC8 (brown and purple), TgDLC8a (blue and green) and PfDLC8 (red and yellow) 
homodimers. The yellow arrow indicates the co-crystallized recognition peptide of HsDLC8. Bottom row: 
Superimposition of the monomer subunits from TgDLC8a and HsDLC8 counterparts based on Cα atoms 
yielded a root mean square deviation of 1.0Å. In contrast, superposition of the monomer subunits from 
TgDLC8a and PfDLC8 counterparts yielded a much higher root mean square deviation (2.4Å). 
 
Similar to dynein light chains, cyclic nucleotides-mediated signaling is expected to govern several 
parasite processes, e.g., lytic cycle and stage differentiation. However, there has been no evidence 
establishing a direct relationship between the activation of the parasite-specific signaling cascade 
and downstream effects because the experimental modulation of cAMP and cGMP in parasites 
has so far relied on chemical modulators that were initially developed to target mammalian cells. 
A chemical approach is suitable for extracellular stages, however not quite for intracellular stages 
enclosed within a mammalian cell, which is perturbed at the same time. To circumvent the issue, 
we conceived optogenetic induction of cyclic nucleotide signaling in T. gondii (Appendix S). Ectopic 
expression of a bacterial photo-activated adenylate cyclase in T. gondii allowed a light-sensitive 




in tachyzoite-bradyzoite conversion and stage-specific gene expression (Fig 18). We showed that 
a transient induction of cytosolic cAMP within the parasite promotes cyst formation, whereas a 
prolonged pulse inhibits this process. We are currently establishing an optimized optogenetically-
regulated system, which would allow us to examine the metabolic, epigenetic and transcriptional 
rewiring in response to cAMP-mediated bidirectional stage switching in T. gondii. Such a model 
shall be valuable to investigate the mechanisms of latency and recrudescence during the parasite 
















Fig 18: Optogenetic induction cAMP-mediated stage differentiation in T. gondii. A light-activated adenylate cyclase 
originally isolated from a lithotropic bacterium Beggiatoa was expressed in a cyst-forming strain of T. gondii. 
Cultures were exposed to blue light, which induces cAMP-dependent stage differentiation in tachyzoites. 
Tachyzoite (green) and bradyzoite (red) stages were visualized by immunostaining of the stage-specific 
TgSag1 and TgCST1 proteins, respectively. 
 
Our parallel work has characterized the native cAMP and cGMP pathways in T. gondii. We have 
identified most of the central mediators present in the parasite, which include at least 4 adenylate 
cyclases (AC1-4), 3 cAMP-dependent kinases (catalytic subunits PKAc1-3 & regulatory subunits 
PKAr1-3), 1 guanylate cyclase, 1 cGMP-dependent kinase (PKG) and 15 phosphodiesterases. 
Initial data indicate an essential nature of cGMP signaling and partly redundant cAMP signaling 
in the hypervirulent strain of T. gondii. In a collaborative study, we examined how cAMP controls 
the process of parasite differentiation (Appendix T). This work revealed that unlike TgPKAc1 and 
TgPKAc2, which are conserved in the phylum apicomplexa, TgPKAc3 appears evolutionarily 
divergent and specific to coccidians. TgPKAc3 was genetically ablated in the cyst-forming as well 
as hypervirulent strains of T. gondii. The Δpkac3 mutant exhibited slower growth that correlated 
with a higher basal rate of bradyzoite formation, which suggests a role of TgPKAc3 in cAMP-
dependent maintenance of the cell cycle. The Δpkac3 mutant also had a defect in producing 
brain cysts, indicating that a substrate of TgPKAc3 probably regulates the persistence in the 
rodent host. We are currently exploring other mediators of cNMP cascades by gene deletion and 




3  CONCLUSIONS AND PERSPECTIVES 
 
This study aimed to appreciate the functioning and impact of metabolic networks in intertwined 
host-parasite models. We strived to fathom the relationships between the metabolic capacities of 
selected parasites, their ability to exploit host metabolism and survive nutritional perturbations, 
which provide clues as to how distinct parasites have evolved with intracellular niches and how to 
inhibit them selectively. Indeed, our work on T. gondii, P. berghei and E. falciformis has proven fairly 
complementary to resolve a number of inter-related premises. In addition, a comparison of their 
metabolic designs with mammalian cells has identified vulnerabilities within parasites’ networks. 
At least, three paradigms emerge from this work, which have potential to advance our knowledge 
even further. 1) Metabolic plasticity and determinants of intracellular parasitism; 2) Physiological 
convergence between parasites and tumor cells; 3) Utility of optogenetics in infection research 
 
3.1  Metabolic plasticity and determinants of intracellular parasitism 
A genome-wide comparison of enzymes and transporters suggested reduced metabolic potential 
and generally host-dependent lifestyles of indicated parasites. Nonetheless, they harbor a nearly 
complete carbon-metabolism framework to produce macromolecules using host-derived carbon 
sources. We determined that glucose and glutamine together furnish a major fraction of biomass 
and energy in a highly co-regulated manner, and such a cooperative metabolism is vital for the 
lytic cycle of T. gondii tachyzoites in mammalian cells. Tachyzoites are also competent in utilizing 
acetate when available, which can rescue the modest growth defect in glycolysis-deficient mutant. 
Unexpectedly, tachyzoites continue to replicate without any of the three primary carbon sources, 
which reflects an exceptional metabolic plasticity, given the facts they are subjected to reductive 
evolution and adapted to strictly intracellular parasitism. Our ongoing work suggests a number of 
other host nutrients exploited by intracellular tachyzoites, especially when the major carbon 
sources become limited. A versatile carbon metabolism with unprecedented nutritional flexibility 
is anticipated to ensure the survival of T. gondii in diverse host-cell types. 
 
Apicomplexans are also competent in producing major phospholipids for membrane biogenesis, 
which is compartmentalized, interlinked, mutually regulated and partially redundant. We reveal 
that Toxoplasma tachyzoites as well as Eimeria sporozoites can utilize host-derived and endogenous 
precursors to manufacture all standard phospholipids, namely PtdCho, PtdEtn, PtdIns, PtdSer, 
PtdGro and PtdOH. Besides, they express some exclusive parasite-specific lipids (PtdThr, EPC, 
IPC), which likely contribute to their specific lifestyle features not shared with mammalian cells. 
Noticeably, lipid biogenesis in both parasites is a patchwork of prokaryotic- and eukaryotic-type 
pathways. Similar to the central carbon metabolism, tachyzoites exhibit a remarkable plasticity in 
phospholipid biogenesis, which include compositional flexibility of membranes, partly redundant 
routes of PtdEtn synthesis and rapid resilience of mutants to genetic or biochemical interference. 
Such characteristics may enable T. gondii tachyzoites to fine-tune membrane synthesis according 
to intracellular milieus encountered in a wide rage of host organisms and plausibly contribute to 




Of note is also the comparison of sugar metabolism in Toxoplasma and Plasmodium, which exhibit a 
striking divergence in carbon metabolism. Plasmodium species lack gluconeogenesis, which renders 
glycolysis essential. The pan-hexose permease appears to be indispensable for all developmental 
stages of Plasmodium and thus offers an attractive drug target. Our PfHT1-transgenic yeast and P. 
berghei models for screening and pharmacological assessment of analog-based drugs shall be useful 
for preclinical evaluation of antimalarials. Physiological essentiality of phylogenetically divergent 
metabolic pathways and certain auxotrophies in parasites provide excellent therapeutic avenues. 
Our proof-of-concept study already demonstrated selective disruption of the lytic cycle by inhibiting 
de novo synthesis of PtdCho as well as the vaccination potential of metabolically attenuated PTS and 
CDS mutants to prevent toxoplasmosis. Collectively, these data underline the translational value 
of our research. Last but not least, our involvement with E. falciformis has identified and validated 
several host factors determining the parasite development. We show how IFNγ signaling plays 
opposing roles during infection and how Eimeria subverts a conserved metabolic pathway of its 
rodent host. This work holds promise to study the impact of host pathways on the entire lifecycle 
of a prevalent coccidian parasite. It is now timely to reconstruct mathematical models of parasite-
host metabolic interactions to deduce the network design principles of parasitism. 
 
3.2 Physiological convergence between parasites and cancer cells 
Over the last decade, a consistent picture of carbon metabolism has emerged from studies on 
diverse types of proliferating cells, whose metabolic requirements are different from differentiated 
(quiescent) cells. For instance, cancer cells must continually produce the major constituents of 
biomass (nucleic acid, protein, membrane). Most differentiated cells however are relieved of such 
liabilities and reduce their carbon flux to promote maintenance and survival. Metabolic demands 
of differentiated cells are primarily met by glucose, most of which (>90%) enters the TCA cycle 
as pyruvate and only a small fraction (<10%) is converted to lactate. Most dividing cells instead 
require rapid glycolytic flux concurrent with the excretion of lactate, and substantial catabolism 
of glutamine and acetate. At first glance, such a carbon flux seems rather inefficient for making 
ATP and the waste of three carbons as lactate; nonetheless, it confers much-needed benefits to 
dividing cells by rerouting glycolytic and TCA cycle metabolites for making biomass.  
 
Intracellular parasites undergoing exponential growth exhibit a cancer-like metabolism, whereas 
extracellular parasites (non-dividing state) appear to depend on the oxidative metabolism, which 
corresponds to differentiated mammalian cells. It therefore appears as though parasites and host 
cells have similar metabolic phenotypes when faced with alike biological fate. This conservation 
implies that there is an evolutionary advantage to non-oxidative metabolism during proliferation 
and to oxidative metabolism during quiescence. Our notion that physiological cooperativity and 
metabolic quintessence of the major carbon sources in T. gondii tachyzoites resembles tumor cells 
may eventually be exploited to develop common therapeutics against both vices. The unicellular 
parasites might also provide pertinent working models to recognize the evolution of proliferative 
metabolism in eukaryotes. A systematic co-modeling of the parasite and cancer cells for example 




the lytic cycle comprises periodic switches between the intracellular proliferative and extracellular 
non-proliferative stages, working with a parasite model (e.g., tachyzoite) may also reveal metabolic 
reprogramming and minimum-essential regulation of proliferation versus quiescence in eukaryotic 
cells. Our work therefore potentially bridges the disciplines of parasitology and tumor biology – 
the consequences of which have yet to be seen. 
 
3.3 Utility of optogenetics in infection research 
The recent success of optogenetics in neurobiology prompted us to establish its initial application 
in infection research using T. gondii as a model pathogen. Specially, the study of cyclic nucleotides 
signaling in T. gondii has proven difficult due to absence of parasite-specific methods and required 
a nonconventional optogenetic approach. Indeed, we were successful in defining many physiological 
roles of the parasite-derived cAMP using an optogenetic actuator. We could achieve an efficient, 
spatial, dynamic and specific induction of the parasite signaling without influencing host cells, 
which has not been feasible by chemical modulators, particularly when working with intracellular 
parasites. Optogenetics has also bestowed other much-desired advantages, such as (a) reversible 
and quantitative modulation of second messengers, (b) gene-encoded activity, which is inheritable 
to the progeny, (c) circumvention of routine issues faced in parasite cultures when using chemicals 
(poor diffusion, premature degradation, sustained effect etc.).  
 
Our founding study has already steered further work on the repression and detection of cNMP-
directed signaling using photo-activated phosphodiesterases and biosensors, respectively. We also 
aim to resolve the ion and phosphoinositide-mediated transduction pathways using light-sensitive 
ion channels and enzymes. Likewise, it is quite conceivable to combine the optogenetic actuators 
of signaling (cNMP, calcium, phosphoinositides etc.) with corresponding gene-encoded sensors to 
photo-oscillate and monitor the processes in real-time. A similar approach using multi-parameter 
imaging can potentially unravel the crosstalk between the signaling cascades. The ever-increasing 
discoveries and tailored engineering of light-responsive proteins and color-tuned isoforms shall 
further widen the dimension of infection research that can be assumed. In brief, integrated utility 
of optogenetics, cell biology and reverse genetics are expected to turn out extremely valuable in 
determining the biological importance of secondary messengers and to examine the endogenous 
signaling machinery in intracellular parasites. We anticipate such a progressive approach will not 
only consolidate optogenetics in parasitology research, but also facilitate its wider application to 
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Martin Blume, Dayana Rodriguez-Contreras, Scott Landfear, Tobias Fleige, Dominique Soldati-
Favre, Richard Lucius, Nishith Gupta 
Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii 
are dispensable by glutaminolysis. Proceedings of National Academy of Sciences USA, 2009, 106 (31): 
12998-3003 
 
Toxoplasma gondii, as an obligate intracellular and promiscuous pathogen of mammalian cells, 
utilizes host sugars for energy and to generate glycoconjugates that are important to its survival 
and virulence. Here, we report that T. gondii glucose transporter (TgGT1) is proficient in 
transporting mannose, galactose, and fructose besides glucose, and serves as a major hexose 
transporter at its plasma membrane. Toxoplasma harbors 3 additional putative sugar transporters 
(TgST1-3), of which TgST2 is expressed at its surface, whereas TgST1 and TgST3 are 
intracellular. Surprisingly, TgGT1 and TgST2 are nonessential to the parasite as their ablations 
inflict only a 30% or no defect in its intracellular growth, respectively. Indeed, Toxoplasma can 
also tolerate the deletion of both genes while incurring no further growth phenotype. Unlike 
Δtgst2, the modest impairment in Δtggt1 and Δtggt1/Δtgst2 mutants is because of a minor delay in 
their intracellular replication, which is a direct consequence of the abolished import of glucose. 
The Δtggt1 displays an attenuated motility in defined minimal media that is rescued by 
glutamine. TgGT1-complemented parasites show an entirely restored growth, motility, and sugar 
import. The lack of exogenous glucose in Δtggt1 culture fails to accentuate its intrinsic growth 
defect and prompts it to procure glutamine to sustain its metabolism. Unexpectedly, in vivo 
virulence of Δtggt1 in mice remains unaffected. Taken together, our data demonstrate that 
glucose is nonessential for T. gondii tachyzoites, underscore glutamine is a complement substrate, 
and provide a basis for understanding the adaptation of T. gondii to diverse host cells. 
 
I initiated this study during my postdoctoral research under the scholastic guidance of RL at Humboldt University 
of Berlin. It serves as the first example of my independent research, which was conceived, directed and partly 
executed by me. The work also constitutes parts of PhD and MS theses submitted by MB under my supervision. 
 
Author contributions: NG and MB designed research; MB, NG, DRC and TF performed research; 
SL, DSF, RL and NG contributed new reagents/analytic tools; MB, NG, DSF and SL analyzed 
data; NG and MB wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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MB, martin.blume@gmail.com; DRC, ddrc70@gmail.com;  
SL, landfear@ohsu.edu; TF, Tobias.Fleige@medecine.unige.ch;  






Martin Blume, Marion Hliscs, Dayana Rodriguez-Contreras, Marco Sanchez, Scott Landfear, 
Richard Lucius, Kai Matuschewski, Nishith Gupta 
A constitutive pan-hexose permease in Plasmodium and models for high-throughput screening of 
anti-malarial sugar analogs. FASEB J, 2011, 25(4): 1218-29 
 
Glucose is considered essential for erythrocytic stages of the malaria parasite, Plasmodium 
falciparum. Importance of sugar and its permease for hepatic and sexual stages of Plasmodium, 
however, remains elusive. Moreover, increasing global resistance to current antimalarials 
necessitates the search for novel drugs. Here, we reveal that hexose transporter 1 (HT1) of 
Plasmodium berghei can transport glucose (Km ~87 μM), mannose (Ki ~93 μM), fructose (Ki ~0.54 
mM), and galactose (Ki ~5 mM) in Leishmania mexicana mutant and Xenopus laevis; and, therefore, is 
functionally equivalent to HT1 of P. falciparum (Glc, Km ~175 μM; Man, Ki ~276 μM; Fru, Ki 
~1.25 mM; Gal, Ki ~5.86 mM). Notably, a glucose analog, C3361, attenuated hepatic (IC50 ~15 
μM) and ookinete development of P. berghei. The PbHT1 could be ablated during 
intraerythrocytic stages only by concurrent complementation with PbHT1-HA or PfHT1. 
Together; these results signify that PbHT1 and glucose are required for the entire life cycle of P. 
berghei. Accordingly, PbHT1 is expressed in the plasma membrane during all parasite stages. To 
permit a high-throughput screening of PfHT1 inhibitors and their subsequent in vivo assessment, 
we have generated Saccharomyces cerevisiae mutant expressing codon-optimized PfHT1, and a 
PfHT1-dependent Δpbht1 parasite strain. This work provides a platform to facilitate the 
development of drugs against malaria, and it suggests a disease-control aspect by reducing 
parasite transmission. 
  
I conceived the study, which was then designed and implemented with the support of coauthors. MB, MH, DRC 
and MS generated most datasets. The work was performed within the framework of PhD dissertation submitted by 
MB under my supervision. 
 
Author contributions: NG and MB designed research; MB, MH, DRC, and MS performed research; 
KM, SL, RL and NG contributed new reagents/analytic tools; MB, NG and KM analyzed data; 
NG and MB wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Appendix C  
 
Richard Nitzsche, Vyacheslav Zagoriy, Richard Lucius, Nishith Gupta 
Metabolic cooperation of glucose and glutamine is essential for the lytic cycle of obligate 
intracellular parasite Toxoplasma gondii. Journal of Biological Chemistry, 2016, 291(1): 126-41 
 
Toxoplasma gondii is a widespread protozoan parasite infecting nearly all warm-blooded organisms. 
Asexual reproduction of the parasite within its host cells is achieved by consecutive lytic cycles, 
which necessitates biogenesis of significant energy and biomass. Here we show that glucose and 
glutamine are the two major physiologically important nutrients used for the synthesis of 
macromolecules (ATP, nucleic acid, proteins, and lipids) in T. gondii, and either of them is 
sufficient to ensure the parasite survival. The parasite can counteract genetic ablation of its 
glucose transporter by increasing the flux of glutamine-derived carbon through the tricarboxylic 
acid cycle and by concurrently activating gluconeogenesis, which guarantee a continued 
biogenesis of ATP and biomass for host-cell invasion and parasite replication, respectively. In 
accord, a pharmacological inhibition of glutaminolysis or oxidative phosphorylation arrests the 
lytic cycle of the glycolysis-deficient mutant, which is primarily a consequence of impaired 
invasion due to depletion of ATP. Unexpectedly, however, intracellular parasites continue to 
proliferate, albeit slower, notwithstanding a simultaneous deprivation of glucose and glutamine. 
A growth defect in the glycolysis-impaired mutant is caused by a compromised synthesis of lipids, 
which cannot be counterbalanced by glutamine but can be restored by acetate. Consistently, 
supplementation of parasite cultures with exogenous acetate can amend the lytic cycle of the 
glucose transport mutant. Such plasticity in the parasite's carbon flux enables a growth-and-
survival trade-off in assorted nutrient milieus, which may underlie the promiscuous survival of T. 
gondii tachyzoites in diverse host cells. Our results also indicate a convergence of parasite 
metabolism with cancer cells. 
 
This work was conceived by myself, and designed together with RN and VZ. RN did most of the experimentation 
and compiled results into a manuscript with my support. The work also constitutes a part of PhD dissertation (to be 
submitted by RN) under my mentorship. 
 
Author contributions: NG conceived, designed, and coordinated the study, analyzed experiments, 
and wrote the paper; RN and VZ designed, performed, and analyzed the experiments and wrote 
the paper; RL contributed analytical tools/reagents. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Martin Blume, Richard Nitzsche, Ulrich Sternberg, Motti Gerlic, Seth L Masters, Nishith 
Gupta, Malcolm J McConville 
A Toxoplasma gondii gluconeogenic enzyme contributes to robust central carbon metabolism and is 
essential for replication and virulence. Cell Host & Microbe, 2015, 18(2): 210-20 
 
The expression of gluconeogenic enzymes is typically repressed when glucose is available. The 
protozoan parasite Toxoplasma gondii utilizes host glucose to sustain high rates of intracellular 
replication. However, despite their preferential utilization of glucose, intracellular parasites 
constitutively express two isoforms of the gluconeogenic enzyme fructose 1,6-bisphosphatase 
(TgFBP1 and TgFBP2). The rationale for constitutive expression of FBPases in T. gondii remains 
unclear. We find that conditional knockdown of TgFBP2 results in complete loss of intracellular 
growth in vitro under glucose-replete conditions and loss of acute virulence in mice. TgFBP2 
deficiency was rescued by expression of catalytically active FBPase and was associated with 
altered glycolytic and mitochondrial TCA cycle fluxes, as well as dysregulation of glycolipid, 
amylopectin, and fatty acid biosynthesis. Futile cycling between gluconeogenic and glycolytic 
enzymes may constitute a regulatory mechanism that allows T. gondii to rapidly adapt to changes 
in nutrient availability in different host cells. 
 
This study originates from the PhD work of MB under my supervision. It was conceptualized and initiated by MB 
and myself at HUB, and continued by MB in MJM’s laboratory at the University of Melbourne. RN and US 
performed additional work needed to ensure the publication while working under my mentorship. 
 
Author contributions: MB, MJM, NG, MG and SLM designed the study; MB, RN, US and MG 
performed assays; MB, MJM and NG wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Appendix E  
 
Richard Nitzsche, Maximilian Tischer, Vyacheslav Zagoriy, Nishith Gupta 
A mitochondrial phosphoenolpyruvate carboxykinase ensures glucose-independent survival of 
the protozoan parasite Toxoplasma gondii (submitted) 
 
Toxoplasma gondii is considered as one of the most successful intracellular pathogens, because it 
can reproduce in varied nutritional milieus, encountered in diverse host-cell types of essentially 
any warm-blood organism. Our earlier work has demonstrated that the acute (tachyzoite) stage 
of T. gondii depends on cooperativity of glucose and glutamine catabolism to sustain its carbon 
demands and underlying metabolic plasticity. The mechanism of glutamine flux and its genetic 
importance in the absence of glucose catabolism remained to be established. Here, we reveal two 
phylogenetically distinctive phosphoenolpyruvate carboxykinase (PEPCK) in the parasite, one of 
which localizes in the mitochondrion (PEPCKmt), whereas the other protein is not expressed in 
tachyzoites (PEPCKnet). Parasites can tolerate genetic deletion of PEPCKmt as well as PEPCKnet, 
indicating nonessential roles of the two isoforms in standard glucose-replete cultures. Moreover, 
PEPCKnet, but not PEPCKmt, could also be ablated in glycolysis-deficient mutant, which implied 
a critical function of the latter enzyme in glucose-independent survival of tachyzoites. In accord, 
the lytic cycle of a conditional mutant of PEPCKmt in the glycolysis-impaired strain was aborted 
following tetracycline-induced repression of the enzyme. Isotope-resolved metabolomics analysis 
of the conditional mutant displayed rather selective defects in glutamine flux into gluconeogenesis 
and pentose phosphate pathway, both of which are required to ensure biomass production in the 
absence of glucose utilization. In addition, our data suggest an anaplerotic role of PEPCKmt that 
enables parasites to interlink glycolysis and TCA cycle under normal glucose-replete conditions. 
Conversely, we found that otherwise-anaplerotic enzyme pyruvate carboxylase is dispensable not 
only in glycolysis-competent strain but also in glycolysis-deficient mutant even though it localizes 
in the parasite mitochondrion. Last but not least, the observed physiology of tachyzoites appears 
to phenocopy cancer cells when faced with similar nutritional environments. Such a metabolic 
convergence holds promise for the development of common therapeutics against both threats. 
 
This study constitutes an extension of RN’s previous work (Appendix C). I conceptualized the research and designed 
it together with RN. The work also constitutes the MS thesis of MT and PhD dissertation of RN (to be submitted) 
under my mentorship.   
 
Author contributions: NG conceived the study; NG and RN designed the work; RN, MT and VZ 
performed research; VZ and NG contributed reagents/analytic tools; RN, VZ and NG analyzed 
data; RN and NG wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the submission of this work. 
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Nishith Gupta, Matthew M Zahn, Isabelle Coppens, Keith A Joiner, Dennis R Voelker 
Selective disruption of phosphatidylcholine metabolism of the intracellular parasite Toxoplasma 
gondii arrests its growth. Journal of Biological Chemistry, 2005, 280(16): 16345–53 
 
Toxoplasma gondii is an intracellular protozoan parasite capable of causing devastating infections in 
immunocompromised and immunologically immature individuals. In this report, we demonstrate 
the relative independence of T. gondii from its host cell for aminoglycerophospholipid synthesis. 
The parasite can acquire the lipid precursors serine, ethanolamine, and choline from its 
environment and use them for the synthesis of its major lipids, phosphatidylserine (PtdSer), 
phosphatidylethanolamine (PtdEtn), and phosphatidylcholine (PtdCho), respectively. 
Dimethylethanolamine (Etn(Me)2), a choline analog, dramatically interfered with the PtdCho 
metabolism of T. gondii and caused a marked inhibition of its growth within human foreskin 
fibroblasts. In tissue culture medium supplemented with 2 mm Etn(Me)2, the parasite-induced 
lysis of the host cells was dramatically attenuated, and the production of parasites was inhibited 
by more than 99%. The disruption of parasite growth was paralleled by structural abnormalities 
in its membranes. In contrast, no negative effect on host cell growth and morphology was 
observed. The data also reveal that the Etn(Me)2-supplemented parasite had a time-dependent 
decrease in its PtdCho content and an equivalent increase in phosphatidyldimethylethanolamine, 
whereas other major lipids, PtdSer, PtdEtn, and PtdIns, remained largely unchanged. Relative to 
host cells, the parasites incorporated more than 7 times as much Etn(Me)2 into their 
phospholipid. These findings reveal that Etn(Me)2 selectively alters parasite lipid metabolism and 
demonstrate how selective inhibition of PtdCho synthesis is a powerful approach to arresting 
parasite growth. 
 
The study stems from my own work performed during the first postdoctoral position under the scholastic supervision 
of DRV at National Jewish Medical Research Center (Denver). The work was conceived and designed by DRV 
and myself. I executed most of the assays and interpreted the data, occasionally aided by MMZ and IC. 
 
Author contributions: NG and DRV designed research; NG, MMZ and IC performed research; IC, 
KAJ and DRV contributed new reagents/analytic tools; NG and DRV analyzed data; NG and 
DRV wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Vera Sampels, Anne Hartmann*, Isabelle Dietrich, Isabelle Coppens, Lilach Sheiner, Boris 
Striepen, Andreas Herrmann§, Richard Lucius, Nishith Gupta  
Conditional mutagenesis of a novel choline kinase demonstrates the plasticity of 
phosphatidylcholine biogenesis and gene expression in Toxoplasma gondii. Journal of Biological 
Chemistry, 2012, 287(20): 16289-99 
 
The obligate intracellular and promiscuous protozoan parasite Toxoplasma gondii needs an 
extensive membrane biogenesis that must be satisfied irrespective of its host-cell milieu. We show 
that the synthesis of the major lipid in T. gondii, phosphatidylcholine (PtdCho), is initiated by a 
novel choline kinase (TgCK). Full-length (≈70-kDa) TgCK displayed a low affinity for choline (Km 
≈0.77 mM) and harbors a unique N-terminal hydrophobic peptide that is required for the 
formation of enzyme oligomers in the parasite cytosol but not for activity. Conditional 
mutagenesis of the TgCK gene in T. gondii attenuated the protein level by ≈60%, which was 
abolished in the off state of the mutant (Δtgcki). Unexpectedly, the mutant was not impaired in its 
growth and exhibited a normal PtdCho biogenesis. The parasite compensated for the loss of full-
length TgCK by two potential 53- and 44-kDa isoforms expressed through a cryptic promoter 
identified within exon 1. TgCK-Exon1 alone was sufficient in driving the expression of GFP in E. 
coli. The presence of a cryptic promoter correlated with the persistent enzyme activity, PtdCho 
synthesis, and susceptibility of T. gondii to a choline analog, dimethylethanolamine. Quite 
notably, the mutant displayed a regular growth in the off state despite a 35% decline in PtdCho 
content and lipid synthesis, suggesting a compositional flexibility in the membranes of the 
parasite. The observed plasticity of gene expression and membrane biogenesis can ensure a 
faithful replication and adaptation of T. gondii in disparate host or nutrient environments. 
 
This work is an extension of my postdoctoral research performed in Denver (Appendix F), which was continued 
when I began my independent work at HUB. My former PhD (VS, AH*) and master (ID) students performed 
most of the experimental work. 
 
Author contributions: NG conceived the study; NG and VS designed research; VS, AH*, ID and NG 
performed research; IC, LS, BS, AH§ and RL contributed reagents and/or analytic tools; NG, 
VS and IC analyzed data; NG and VS wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Nishith Gupta, Anne Hartmann, Richard Lucius, Dennis R Voelker  
The obligate intracellular parasite Toxoplasma gondii secretes a soluble phosphatidylserine 
decarboxylase. Journal of Biological Chemistry, 2012, 287(27): 22938-47 
 
Toxoplasma gondii is an obligate intracellular parasite capable of causing fatal infections in 
immunocompromised individuals and neonates. Examination of the phosphatidylserine (PtdSer) 
metabolism of T. gondii reveals that the parasite secretes a soluble form of PtdSer decarboxylase 
(TgPSD1), which preferentially decarboxylates liposomal PtdSer with an apparent Km of 67 μM. 
The specific enzyme activity increases by 3-fold during the replication of T. gondii, and soluble 
phosphatidylserine decarboxylase (PSD) accounts for ≈20% of the total PSD, prior to the 
parasite egress from the host cells. Extracellular T. gondii secreted ≈20% of its total PSD activity 
at 37°C, and the intracellular Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-
tetraacetic acid tetrakis (acetoxymethyl ester) inhibited the process by 50%. Cycloheximide, 
brefeldin A, ionic composition of the medium, and exogenous PtdSer did not modulate the 
enzyme secretion, which suggests a constitutive discharge of a presynthesized pool of PSD in 
axenic T. gondii. TgPSD1 consists of 968 amino acids with a 26-amino acid hydrophobic peptide 
at the N terminus and no predicted membrane domains. Parasites overexpressing TgPSD1-HA 
secreted 10-fold more activity compared with the parental strain. Exposure of apoptotic Jurkat 
cells to transgenic parasites demonstrated interfacial catalysis by secreted TgPSD1 that reduced 
host cell surface exposure of PtdSer. Immunolocalization experiments revealed that TgPSD1 
resides in the dense granules of T. gondii and is also found in the parasitophorous vacuole of 
replicating parasites. Together, these findings demonstrate novel features of the parasite enzyme 
because a secreted, soluble, and interfacially active form of PSD has not been previously 
described for any organism. 
 
This study originates from the experimental work performed during my first postdoctoral position under the guidance 
of DRV at National Jewish Medical Research Center (Denver). The work was conceived and designed by myself 
with DRV’s support. I generated most datasets and drafted a manuscript for submission while working in Denver, 
which required additional assays done by AH to ensure the publication. AH has reported her contribution in a PhD 
dissertation under my mentorship. 
 
Author contributions: NG and DRV designed research; NG and AH performed research; DRV and 
RL contributed new reagents and analytical tools; NG and AH analyzed data; NG wrote the 
paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Anne Hartmann, Maria Hellmund, Richard Lucius, Dennis R Voelker, Nishith Gupta 
Phosphatidylethanolamine synthesis in the parasite mitochondrion is required for efficient 
growth but dispensable for survival of Toxoplasma gondii. Journal of Biological Chemistry, 2014, 
289(10): 6809-24 
 
Toxoplasma gondii is a highly prevalent obligate intracellular parasite of the phylum Apicomplexa, 
which also includes other parasites of clinical and/or veterinary importance, such as Plasmodium, 
Cryptosporidium, and Eimeria. Acute infection by Toxoplasma is hallmarked by rapid proliferation in 
its host cells and requires significant synthesis of parasite membranes. Phosphatidylethanolamine 
(PtdEtn) is the second major phospholipid class in T. gondii. Here, we reveal that PtdEtn is 
produced in the parasite mitochondrion and parasitophorous vacuole by decarboxylation of 
phosphatidylserine (PtdSer) and in the endoplasmic reticulum by fusion of CDP-ethanolamine 
and diacylglycerol. PtdEtn in the mitochondrion is synthesized by a phosphatidylserine 
decarboxylase (TgPSD1mt) of the type I class. TgPSD1mt harbors a targeting peptide at its N 
terminus that is required for the mitochondrial localization but not for the catalytic activity. 
Ablation of TgPSD1mt expression caused up to 45% growth impairment in the parasite mutant. 
The PtdEtn content of the mutant was unaffected, however, suggesting the presence of 
compensatory mechanisms. Indeed, metabolic labeling revealed an increased usage of 
ethanolamine for PtdEtn synthesis by the mutant. Likewise, depletion of nutrients exacerbated 
the growth defect (≈56%), which was partially restored by ethanolamine. Besides, the survival 
and residual growth of the TgPSD1mt mutant in the nutrient-depleted medium also indicated 
additional routes of PtdEtn biogenesis, such as acquisition of host-derived lipid. Collectively, the 
work demonstrates a metabolic cooperativity between the parasite organelles, which ensures a 
sustained lipid synthesis, survival and growth of T. gondii in varying nutritional milieus. 
 
I conceived and supervised this work, which was executed within the framework of PhD dissertation of AH and 
master’s thesis of MH. I also did a minor part of this work when working as a postdoctoral fellow in Denver. 
 
Author contributions: NG conceived the study; NG and AH designed research; AH, MH and NG 
performed research; RL and DRV contributed new analytical reagents; AH and NG analyzed 
data and wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
 
Coauthors’ emails: 
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Ruben D Arroyo-Olarte, Jos F Brouwers, Arunakar Kuchipudi, Bernd J Helms, Aindrilla Biswas, 
Ildiko R Dunay, Richard Lucius, Nishith Gupta  
Phosphatidylthreonine and lipid-mediated control parasite virulence. PLoS Biology, 2015, 13(11): 
e1002288 
 
The major membrane phospholipid classes, described thus far, include phosphatidylcholine 
(PtdCho), phosphatidylethanolamine (PtdEtn), phosphatidylserine (PtdSer), and 
phosphatidylinositol (PtdIns). Here, we demonstrate the natural occurrence and genetic origin of 
an exclusive and rather abundant lipid, phosphatidylthreonine (PtdThr), in a common eukaryotic 
model parasite, Toxoplasma gondii. The parasite expresses a novel enzyme PtdThr synthase 
(TgPTS) to produce this lipid in its endoplasmic reticulum. Genetic disruption of TgPTS 
abrogates de novo synthesis of PtdThr and impairs the lytic cycle and virulence of T. gondii. The 
observed phenotype is caused by a reduced gliding motility, which blights the parasite egress and 
ensuing host cell invasion. Notably, the PTS mutant can prevent acute as well as yet-incurable 
chronic toxoplasmosis in a mouse model, which endorses its potential clinical utility as a 
metabolically attenuated vaccine. Together, the work also illustrates the functional speciation of 
two evolutionarily related membrane phospholipids, i.e. PtdThr and PtdSer. 
 
This work was envisaged and initiated by myself. RDAO continued the work and performed most experiments. The 
study also constitutes a major part of RDAO’s PhD thesis under my mentorship. 
 
Author contributions: NG and RDAO conceived and designed the experiments; RDAO, JFB, AK, 
AB and IRD performed the experiments; RDAO, JFB, IRD and NG analyzed the data; RL, 
BJH and NG contributed reagents/materials/analysis tools; NG and RDAO wrote the paper. All 
authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
 
Coauthors’ emails: 
RDAO, rubendao@gmail.com; JFB, j.brouwers@uu.nl;  
AK, arunakar.kuchipudi@hu-berlin.de; BJH, J.B.Helms@uu.nl;  







Arunakar Kuchipudi, Ruben D Arroyo-Olarte, Friederike Hoffmann, Volker Brinkmann, 
Nishith Gupta  
Optogenetic monitoring identifies phosphatidylthreonine-regulated calcium homeostasis in 
Toxoplasma gondii. Microbial Cell, 2016, 3(5): 215-23 
 
Toxoplasma gondii is an obligate intracellular parasite, which inflicts acute as well as chronic 
infections in a wide range of warm-blooded vertebrates. Our recent work has demonstrated the 
natural occurrence and autonomous synthesis of an exclusive lipid phosphatidylthreonine in T. 
gondii. Targeted gene disruption of phosphatidylthreonine synthase impairs the parasite virulence 
due to unforeseen attenuation of the consecutive events of motility, egress and invasion. 
However, the underlying basis of such an intriguing phenotype in the parasite mutant remains 
unknown. Using an optogenetic sensor (gene-encoded calcium indicator, GCaMP6s), we show 
that loss of phosphatidylthreonine depletes calcium stores in intracellular tachyzoites, which leads 
to dysregulation of calcium release into the cytosol during the egress phase of the mutant. 
Consistently, the parasite motility and egress phenotypes in the mutant can be entirely restored 
by ionophore-induced mobilization of calcium. Collectively, our results suggest a novel 
regulatory function of phosphatidylthreonine in calcium signaling of a prevalent parasitic protist. 
Moreover, our application of an optogenetic sensor to monitor subcellular calcium in a model 
intracellular pathogen exemplifies its wider utility to other entwined systems. 
 
This is a direct extension of previous work (Appendix J). AK, RDAO and FH performed experiments under my 
supervision. The work has been reported partly by RDAO in his PhD thesis and by FH in her master’s research 
module, while AK will report the rest in his PhD work.  
 
Author contributions: NG and RDAO conceived and designed the study; AK, RDAO and FH 
performed the assays; NG, AK and RDAO analyzed the data; VB and NG contributed reagents 
and analysis tools; NG, RDAO and AK wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Ruben D Arroyo-Olarte, Nishith Gupta 
Phosphatidylthreonine: An exclusive phospholipid regulating calcium homeostasis and virulence 
in a parasitic protist. Microbial Cell, 2016, 3(5): 189-190 
 
This is a micro-review based on work mentioned in Appendix J and Appendix K. RDAO and I wrote this review 







Pengfei Kong, Christoph-Martin Ufermann, Qing Yin, Xun Suo, Bernd J Helms, Jos F 
Brouwers, Nishith Gupta  
Two distinct CDP-diacylglycerol synthases in the parasite ER and apicoplast cooperate to ensure 
lipid biogenesis in Toxoplasma gondii (submitted) 
 
Phosphatidic acid (PtdOH) serves as the universal precursor to produce all major phospholipids. 
In eukaryotes, PtdOH is converted into cytidine diphosphate-diacylglycerol (CDP-DAG) and 
diacylglycerol (DAG), which are subsequently utilized as substrates by various enzymes of lipid 
synthesis. Here, we report the occurrence of two phylogenetically divergent CDP-DAG synthase 
(CDS) enzymes in a prevalent parasitic protist Toxoplasma gondii. The eukaryotic-type TgCDS1 is 
located in the endoplasmic reticulum, whereas the prokaryotic-type TgCDS2 resides in the 
apicoplast (a plastid relict) of the parasite. While orthologs of TgCDS1 appears to be conserved 
across the eukaryotic phyla, homologs of TgCDS2 could only be found in bacteria, plants, algae 
and selected protozoan parasites including Eimeria, Trypanosoma and Leishmania species. 
Conditional knockdown of TgCDS1 severely attenuated the growth of T. gondii, which translated 
into a nearly complete loss of virulence in a mouse model. Besides, mice infected with the 
TgCDS1 mutant became categorically resistant to the challenge infection with a hypervirulent 
strain of T. gondii. The residual growth of the TgCDS1 mutant was abolished by subsequent 
deletion of TgCDS2, indicating that the host cell is unable to recompense the ablation of 
parasite’s endogenous pathways of CDP-DAG synthesis. Lipidomics analyses of the parasite 
mutants revealed significant and rather specific decline in phosphatidylinositol (made in Golgi) 
upon genetic repression of TgCDS1. Equally, deletion of TgCDS2 selectively impaired the 
biogenesis of phosphatidylglycerol in the mitochondrion. Our data show a ‘division of labor’ model 
of lipid biogenesis and inter-organelle trafficking, in which two discrete pools of CDP-DAG 
produced in the ER and apicoplast are subsequently utilized to synthesize phosphatidylinositol in 
the Golgi bodies and phosphatidylglycerol in the mitochondrion. Essential and divergent nature 
of CDP-DAG synthesis offers a validated drug target to inhibit the parasite reproduction. 
 
This study was envisioned and directed by me. PK performed most assays. The research also constitutes PhD work 
of PK and the master’s research module of CMU under my mentorship. 
 
Author contributions: NG conceived the work; NG and PK designed the study; PK, CMU and QY 
performed the assays; NG, PK and JFB analyzed the data; BJH, JFB, XS and NG contributed 
reagents and analysis tools; PK and NG wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the submission of this work. 
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Pengfei Kong, Stefanie Brandt, Jos F Brouwers, Bernd J Helms, Richard Lucius, Nishith Gupta 
Expression of exclusive phospholipids and autonomous membrane biogenesis indicate a host-
independent lifestyle of Eimeria sporozoites (in preparation) 
 
Apicomplexan parasites infect a wide range of invertebrate and vertebrate organisms and impose 
substantial healthcare and socioeconomic burden globally. The natural lifecycle of apicomplexan 
parasites involves alternating sexual an asexual reproduction occurring either in one or two hosts. 
The completion of sexual development is hallmarked by formation of the oocyst stage, which 
sporulates to produce the infective sporozoite stage for transmission to the next host. Despite its 
pivotal importance for inter-host transmission, the sporozoite biology remains poorly understood, 
primarily due to inaccessibility of this stage in sufficient amounts. In particular, the sporozoite 
metabolism is profoundly interesting from a conceptual viewpoint, because this is the only freely 
developing stage of apicomplexan parasites. It allows assessment of the ‘true’ metabolic potential 
of a parasite independent of host cell, while offering drug targets to block transmission. This work 
utilized Eimeria falciformis, which completes its entire development in mouse, and thus bestows a 
decent model to examine the sporozoite biology. We studied membrane biogenesis in the mature 
sporozoites purified from oocysts. Lipidomics analyses revealed that PtdCho (79%) and PtdEtn 
(13%) are the two most abundant lipids accounting for >90% of total isolated phospholipids in 
sporozoites, whereas PtdIns (1.5%) and PtdSer (0.5%) occur only as minor lipids. Moreover, 
unlike mammalian host cells, Eimeria sporozoites also express certain rare lipids, such as PtdThr 
and inositol-phosphorylceramide. We identified, experimentally-annotated and localized most of 
the enzymes of phospholipid biogenesis in sporozoites. In brief, we show that lipid synthesis is an 
evolutionary patchwork of eukaryotic and prokaryotic-type pathways located in the endoplasmic 
reticulum, mitochondrion, Golgi bodies, dense granules as well as apicoplast (a chloroplast relict). 
Collectively, this study demonstrates that the sporozoite stage is designed to be autonomous with 
respect to lipid biogenesis, which is a phylogenetic mosaic of inter-linked, compartmentalized and 
exclusive pathways. Our groundwork on membrane biogenesis of the sporozoite stage provides a 
sound basis to understand the network design principles of intracellular parasitism. 
	  
The study originates from our work on the membrane biogenesis of T. gondii (Appendix F-L). PK and SB, who 
performed most assays, will report this work in their PhD and BS theses, respectively, under my mentorship. 
 
Author contributions: NG and PK conceived and designed the study; PK and SB performed the 
experiments; BJH, JFB, RL and NG contributed new reagents and analytical tools; PK, NG and 
JFB analyzed the data; PK and NG are preparing the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) will be made by all coauthors during the submission of this work. 
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Manuela Schmid, Emanuel Heitlinger, Simone Spork, Hans P Mollenkopf, Richard Lucius, 
Nishith Gupta 
Eimeria falciformis infection of the mouse caecum identifies opposing roles of IFNγ-regulated host 
pathways for the parasite development. Mucosal Immunology, 2014, 7(4): 969-82 
 
Intracellular parasites reprogram host functions for their survival and reproduction. The extent 
and relevance of parasite-mediated host responses in vivo remains poorly studied, however. We 
utilized Eimeria falciformis, a parasite infecting the mouse intestinal epithelium, to identify and 
validate host determinants of parasite infection. Most prominent mouse genes induced during the 
onset of asexual and sexual growth of parasite comprise interferon γ (IFNγ)-regulated factors, e.g., 
immunity-related GTPases (IRGA6, B6, D, M2, M3), guanylate-binding proteins (GBP2, 3, 5, 6, 
8), chemokines (CxCL9-11), and several enzymes of the kynurenine pathway including 
indoleamine 2,3-dioxygenase 1 (IDO1). These results indicated a multifarious innate defense 
(tryptophan catabolism, IRG, GBP, and chemokine signaling), and a consequential adaptive 
immune response (chemokine-cytokine signaling and lymphocyte recruitment). The 
inflammation- and immunity-associated transcripts were increased during the course of infection, 
following influx of B cells, T cells, and macrophages to the parasitized caecum tissue. 
Consistently, parasite growth was enhanced in animals inhibited for CxCr3, a major receptor for 
CxCL9-11 present on immune cells. Interestingly, despite a prominent induction, mouse IRGB6 
failed to bind and disrupt the parasitophorous vacuole, implying an immune evasion by E. 
falciformis. Furthermore, oocyst output was impaired in IFNγ-R-/- and IDO1-/- mice, both of 
which suggest a subversion of IFNγ signaling by the parasite to promote its growth. 
 
I conceived the study. MS performed most of the experiments and reported this work in her PhD thesis, concluded 
under my supervision. 
 
Author contributions: NG and MS designed the study; MS and SS performed the experiments; EH, 
HPM, and RL contributed new reagents and analysis tools; NG, MS and EH analyzed the data; 
MS and NG wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Manuela Schmid, Maik J Lehmann, Richard Lucius, Nishith Gupta  
Apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle 
progression in the mouse. Journal of Biological Chemistry, 2012, 287(24): 20197-207 
 
The obligate intracellular apicomplexan parasites, e.g., Toxoplasma gondii and Plasmodium species, 
induce an IFNγ-driven induction of host indoleamine 2,3-dioxygenase (IDO), the first and rate-
limiting enzyme of tryptophan catabolism in the kynurenine pathway. Induction of IDO1 
supposedly depletes cellular levels of tryptophan in host cells, which is proposed to inhibit the in 
vitro growth of auxotrophic pathogens. In vivo function of IDO during infections, however, is not 
clear, let alone controversial. We show that Eimeria falciformis, an apicomplexan parasite infecting 
the mouse caecum, induces IDO1 in the epithelial cells of the organ, and the enzyme expression 
coincides with the parasite development. The absence or inhibition of IDO1/2 and of two 
downstream enzymes in infected animals is detrimental to the Eimeria growth. The reduced 
parasite yield is not due to a lack of an immunosuppressive effect of IDO1 in the parasitized 
IDO1-/- or inhibitor-treated mice because they did not show an accentuated Th1 and IFNγ 
response. Noticeably, the parasite development is entirely rescued by xanthurenic acid, a by-
product of tryptophan catabolism inducing exflagellation in male gametes of Plasmodium in the 
mosquito mid-gut. Our data demonstrate a conceptual subversion of the host defense (IFNγ, 
IDO) by an intracellular pathogen for progression of its natural life cycle. Besides, we show utility 
of E. falciformis, a monoxenous parasite of a well-appreciated host, i.e. mouse, to identify in vivo 
factors underlying the parasite-host interactions. 
 
This work was envisaged by myself, and designed with the assistance of MS. MS performed most experiments. 
Together with Appendix O, this study constitutes a major part of MS’s PhD dissertation under my mentorship. 
 
Author contributions: NG and MS designed the study; MS and MJL performed the experiments; RL 
contributed new reagents/tools; MS and NG analyzed the data and wrote the paper. All authors 
approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Bingjian Ren, Manuela Schmid, Hans P Mollenkopf, Emanuel Heitlinger, Nishith Gupta 
Apicomplexan parasites, Toxoplasma gondii and Eimeria falciformis, induce and co-opt a master 
transcription factor cFos in mammalian host cell (in preparation) 
 
The protozoan phylum apicomplexa comprises more than 6000 parasite species, most of which 
are adapted to obligate intracellular parasitism in vertebrate and invertebrate organisms. Here, 
we deployed two related intracellular parasites, namely Toxoplasma gondii and Eimeria falciformis, 
infecting a shared host (i.e. mouse) to identify the host determinants of infection. Gene expression 
analyses of the young adult mouse colon epithelial cells infected with individual parasites revealed 
a notably distinct host response, indicating that irrespective of their phylogenetic proximity, both 
pathogens reprogram their corresponding niches in a markedly tailored manner. As expected, we 
detected a repertoire of host defense pathways, such as JAK-STAT, TLR and MAPK signaling 
and cytokine-receptor interaction, majority of which are regulated by IFNγ in response to 
infection. More importantly, our analyses revealed only two genes (encoding for cFos and Rab24 
proteins) that were consistently induced by both parasites at early as well as late time points. 
Rab24 belongs to a small GTPase family likely involved in autophagy, whereas cFos is a well-
known master transcription factor and a proto-oncogene, which governs diverse processes, 
including but not limited to, proliferation, apoptosis, inflammation and oncogenesis. In-depth 
phenotyping of T. gondii in mouse embryonic fibroblasts lacking the expression of cFos showed 
that the protein was needed for the parasite replication. Plaque assays using the cFos-/- mutant 
cells confirmed an apparently essential function of host cFos for the lytic cycle of T. gondii. 
Likewise, the asexual reproduction of E. falciformis was significantly impaired in the cFos-
knockout cells. Taken together, our results signify potential subversion of a central host factor by 
the two intracellular parasites to promote their own development. 
 
This is an extension of previous work (Appendix O-P). MS generated most of the datasets, which were reanalyzed 
and completed by BR. MS has reported a major part of this work in her PhD thesis under my supervision. 
 
Author contributions: NG conceived the work; NG and MS designed the study; MS and BR 
performed the experiments; EH and HPM contributed reagents and analysis tools; MS, BR and 
NG analyzed the data; BR and NG are preparing the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) will be made by all coauthors during the submission of this work. 
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Bilal Qureshi, Natalie E Hoffmann, Ruben D Arroyo-Olarte, Bernadette Nickl, Wolfgang 
Höhne, Peter R Jungblut, Richard Lucius, Patrick Scheerer, Nishith Gupta 
Dynein Light Chain 8a of Toxoplasma gondii, a unique conoid-localized β-strand-swapped 
homodimer, is required for an efficient parasite growth. FASEB J, 2013, 27(3): 1034-47  
   
Dynein light chain 8 (DLC8) is a ubiquitous eukaryotic protein regulating diverse cellular 
functions. We show that the obligate intracellular parasite Toxoplasma gondii harbors 4 DLC8 
proteins (TgDLC8a-d), of which only TgDLC8a clusters in the mainstream LC8 class. TgDLC8b-
d proteins form a divergent and alveolate-specific clade. TgDLC8b-d proteins are largely 
cytosolic, whereas TgDLC8a resides in the conoid at the apical end of T. gondii. The apical 
location of TgDLC8a is also not shared by its nearly identical Eimeria (EtDLC8a), Plasmodium 
(PfDLC8), or human (HsDLC8) orthologs. Notwithstanding an exclusive conoid targeting, 
TgDLC8a exhibits a classical LC8 structure. It forms a homodimer by swapping of the β strands 
that interact with the antiparallel β' strands of the opposing monomers. The TgDLC8a dimer 
contains two identical binding grooves and appears to be adapted for multitarget recognition. By 
contrast, the previously reported PfDLC8 homodimer is shaped by binding of the β strand with 
the parallel β' strand and lacks such a distinct binding interface. Our comparisons suggest an 
unexpected structural and functional divergence of the two otherwise conserved proteins from 
apicomplexan parasites. Finally, we demonstrate that a phosphomimetic S88E mutation renders 
the TgDLC8a-S88E mutant monomeric and cytosolic in T. gondii, and its overexpression inhibits 
the parasite growth in human fibroblasts. 
 
The work was conceived by me, and directed together with PS. The study was designed with the support of BQ and 
PS. BQ and NEH performed most assays, aided or facilitated by RDAO and BN. BQ and NEH have reported 
this work in their master’s thesis under my supervision. 
 
Author contributions: NG conceived the study; NG, BQ and PS designed the work; BQ, NEH, BN 
and RDAO performed the assays; RL, WH and PRJ contributed new reagents and analysis tools; 
NG, BQ and PS analyzed the data and wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Anne Hartmann, Ruben D Arroyo-Olarte, Katharina Imkeller, Peter Hegemann, Richard 
Lucius, Nishith Gupta 
Optogenetic modulation of an adenylate cyclase in Toxoplasma gondii demonstrates a requirement 
of parasite cAMP for host-cell invasion and stage differentiation. Journal of Biological Chemistry, 
2013, 288(19): 13705-17 
 
Successful infection and transmission of the obligate intracellular parasite Toxoplasma gondii 
depends on its ability to switch between fast-replicating tachyzoite (acute) and quiescent 
bradyzoite (chronic) stages. Induction of cAMP in the parasitized host cells has been proposed to 
influence parasite differentiation. It is not known whether the parasite or host cAMP is required 
to drive this phenomenon. Other putative roles of cAMP for the parasite biology also remain to 
be identified. Unequivocal research on cAMP-mediated signaling in such intertwined systems 
also requires a method for an efficient and spatial control of the cAMP pool in the pathogen or in 
the enclosing host cell. We have resolved these critical concerns by expressing a photoactivated 
adenylate cyclase that allows light-sensitive control of the parasite or host-cell cAMP. Using this 
method, we reveal multiple roles of the parasite-derived cAMP in host-cell invasion, stage-specific 
expression, and asexual differentiation. An optogenetic method provides many desired 
advantages, such as (i) rapid, transient and efficient cAMP induction in extracellular/intracellular 
and acute/chronic stages; (ii) circumvention of the difficulties often faced in cultures, i.e. poor 
diffusion, premature degradation, steady activation, and/or pleiotropic effects of cAMP agonists 
and antagonists; (iii) genetically encoded enzyme expression, thus inheritable to the cell progeny; 
and (iv) conditional and spatiotemporal control of cAMP levels. Importantly, a successful 
optogenetic application in Toxoplasma also illustrates its wider utility to study cAMP-mediated 
signaling in other genetically amenable two-organism systems, such as in symbiotic and 
pathogen-host models. 
 
I conceived and designed the study, and supervised AH and RDAO (PhD students), who equally contributed to the 
results. The work was partly assisted by a master’s student KI. 
 
Author contributions: NG conceived and designed the work; AH, RDAO and KI performed the 
experiments; RL and PH contributed new reagents and analytical tools; NG, AH and RDAO 
analyzed the data; NG, AH and RDAO wrote the paper. All authors approved the manuscript. 
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
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Tatsuki Sugi, Yan Fen Ma, Tadakimi Tomita, Fumi Murakoshi, Michael S Eaton, Rama 
Yakubu, Bing Han, Vincent Tu, Kentaro Kato, Shin-Ichiro Kawazu, Nishith Gupta, Elena S 
Suvorova, Michael W White, Kami Kim, Louis M Weiss 
Toxoplasma gondii cAMP-dependent protein kinase subunit 3 is involved in the switch from 
tachyzoite to bradyzoite development. mBio, 2016, 7(3): e00755-16 
 
Toxoplasma gondii is an obligate intracellular apicomplexan parasite that infects warm-blooded 
vertebrates, including humans. Asexual reproduction in T. gondii allows it to switch between the 
rapidly replicating tachyzoite and quiescent bradyzoite life cycle stages. A transient cyclic AMP 
(cAMP) pulse promotes bradyzoite differentiation, whereas a prolonged elevation of cAMP 
inhibits this process. We investigated the mechanism(s) by which differential modulation of 
cAMP exerts a bidirectional effect on parasite differentiation. There are three protein kinase A 
(PKA) catalytic subunits (TgPKAc1-3) expressed in T. gondii. Unlike TgPKAc1 and TgPKAc2, 
which are conserved in the phylum Apicomplexa, TgPKAc3 appears evolutionarily divergent 
and specific to coccidian parasites. TgPKAc1 and TgPKAc2 are distributed in the 
cytomembranes, whereas TgPKAc3 resides in the cytosol. TgPKAc3 was genetically ablated in a 
type II cyst-forming strain of T. gondii (PruΔku80Δhxgprt) and in a type I strain (RHΔku80Δhxgprt), 
which typically does not form cysts. The Δpkac3 mutant exhibited slower growth than the 
parental and complemented strains, which correlated with a higher basal rate of tachyzoite-to-
bradyzoite differentiation. 3-Isobutyl-1-methylxanthine (IBMX) treatment, which elevates cAMP 
levels, maintained wild-type parasites as tachyzoites under bradyzoite induction culture 
conditions (pH 8.2/low CO2), whereas the Δpkac3 mutant failed to respond to the treatment. 
This suggests that TgPKAc3 is the factor responsible for the cAMP-dependent tachyzoite 
maintenance. In addition, the Δpkac3 mutant had a defect in the production of brain cysts in 
vivo, suggesting that a substrate of TgPKAc3 is probably involved in the persistence of this 
parasite in the intermediate host animals. 
 
I have not been involved in conceiving, designing and performing this work, which was predominantly a cumulative 
effort of LMW, KK and TS. I have played an advisory role, contributed analytical tools and edited the manuscript. 
 
Author contributions: LMW, KK and TS conceived and designed the work; TS, YFM, TT, FM, 
MSE, RY, BH and VT performed the experiments; KK, SIK, NG, ESS and MWW contributed 
reagents and analytical tools; TS, LMW and KK analyzed the data and wrote the paper. All 
authors approved the manuscript.  
 
All necessary declarations pertaining to this research (acknowledgments, conflict of interests, data 
deposition etc.) have been made by all coauthors during the publication of this work. 
 
Coauthors’ emails: 
TS, tatsuki.sugi@gmail.com; YFM, yanfen.ma@einstein.yu.edu;  
TT, tadakimi.tomita@einstein.yu.edu; FM, murakoshi@obihiro.ac.jp;  
MSE, eaton.michael@gmail.com; RY, ramarasheed.yakubu@med.einstein.yu.edu;  
BH, bing.han@einstein.yu.edu; VT, vitu1@mail.einstein.yu.edu; KK, kkato@obihiro.ac.jp;  
SIK, skawazu@obihiro.ac.jp; ESS, essuvorova@gmail.com; MWW, mwhite.usf@gmail.com; 






It is already 13 years since I turned to the long winding path of molecular parasitology, and there 
has been no look back since then. I am still learning to drive despite the fact that many excellent 
mentors have invested an ample amount of time and effort to nurture me. I wish to profoundly 
thank Richard Lucius, who has been an excellent guide and a wonderful adviser since April 
2006. It is in fact a Herculean task for me to describe the number of occasions when I needed 
him most. Literally speaking, he charmed me to drive in Berlin from the mile-high city Denver. 
He provided me a decent car (laboratory), gasoline (seed funds), upkeep staff (technician) and the 
freedom to venture on a racetrack (research program) of my own choice. Having driven in the 
United States, I was pampered with cheap gasoline (superfluous research funds), lenient traffic 
rules (ease of doing work) and wider roads (diversity of research and interactions). It was not easy 
to adjust, improve and sustain my driving skills while training the next generation of drivers 
(young scientists). But guess what… he was always there. He frequently responded to my queries 
in off-hours, giving me a feeling that he truly cared for me. His relentless support has often gone 
beyond science. For instance, he helped me to build my personal life and family in Germany. 
Can never appreciate him enough in words. Thank you very much RICHARD. 
 
Next one to thank is Dennis Voelker, my postdoctoral mentor (and now collaborator), who gave 
me the very first opportunity to start driving in the terrain of molecular parasitology. Not 
knowing much about how well I would fare with parasites, it was indeed not easy to switch fields 
after my PhD in Biochemistry. I was clearly not aware of the pitfalls and potholes along the road. 
Ironically, Dennis was also venturing first time in this territory. Nonetheless, some primary traffic 
rules and rather uncommon commonsense (the art of doing science) learnt from Dennis enabled 
me to spearhead a new territory. I am deeply inspired by his way of doing science, where 
consistent and gold standard performance matter more than bumpy rides. Other valuable tenets, 
I picked up from him are ‘maliciousness is simply unfamiliarity with things’, and ‘the absence of evidence 
doesn’t mean the evidence of absence’. Then, there are two more coaches, Kai Matuschewski and Peter 
Hegemann, who greatly improved my driving skills by offering much-needed advices, hardcore 
support and recommendations when I needed. Each and every meeting I had with them steered 
me into the right direction, and often rekindled my mind to think beyond the obvious. Thank 
you very much DENNIS, KAI and PETER for your continued support. 
 
I am also obliged to Hermann-Georg Holzhütter and Andreas Herrmann, co-applicants in the 
first two grants of mine, which were indispensable to kick-start a long-drive. Even though I never 
quite fathomed their research fields (system biology, biophysics), I did learn two must-learn tacts: 
writing grants and being interdisciplinary. Then there are several collaborators and cooperation 
partners, particularly Isabelle Coppens, Scott Landfear, Dominique Soldati-Favre, Bernd Helms, 
Jos Brouwers, Hans Mollenkopf, Wolfgang Höhne, Ildiko Dunay, Vyacheslav Zagoriy, Volker 
Brinkmann and Emanuel Heitlinger, all of whom have reinforced our work by contributing 
complementary expertise. I am also very indebted to many facilitators, Boris Striepen, John 
Boothroyd, Vern Carruthers, Markus Meissner, David Bzik, Peter Bradley, Sergio Angel, Louis 
Weiss and Jean-François Dubremetz, who have kept our automobile running by donating 
precious spare parts (biological resources) at their earliest possible convenience. I want to pay my 
special gratitude to Grit Meusel, our vital upkeep staff. I tenderly call her the ‘mother of our lab’, 
which is quite the right description for an important person like her. No one notices the people 




scene personnel are actually the lynchpin in any discipline, be it science or Hollywood Sci-Fi. I 
also take this opportunity to acknowledge two other colleagues in the department, Susanne 
Hartmann and Maik Lehmann for their occasional active support. 
 
Now that I have my own driving school for the next-generation drivers (lab members), it is worth 
saluting what I have learnt while training them. A series of PhD, MS and BS students including 
Martin Blume, Manuela Schmid, Vera Sampels, Ruben Dario Arroyo-Olarte, Anne Hartmann, 
Pengfei Kong, Richard Nitzsche, Arunakar Kuchipudi, Matthias Noll, Ozlem Günay, Laura 
Radtke, Bingjian Ren, Stefanie Brandt, Theresa Ring, Julian Kreibich, Aline Hössler, Leska 
Balken, Fatima Hedar, Lucas Niedersen, Ludmila Lobkowicz, Isabelle Dietrich, Annabell 
Bachem, Bilal Qureshi, Clemens Falker, Natalie Hofmann, Ulrich Sternberg, Stephan 
Marquardt, Maximilian Tischer, Tobias Kletter, Maria Hellmund, Katharina Imkeller, Stefania 
Chiocchetti, Nicola Schaltenberg, Friederike Hoffmann, Bernadette Nickl, Ines Heyn, Christina 
Wangen, Jennifer Oduro, Marjorie Linares, Kathrin Frenzel, Christoph-Martin Uffermann, 
Diana Zimmermann, Mareen Lüthen and Julieta Cuellar, all of whom worked really hard (and 
smart) to get my car going for a long drive. Going along the way, they came up with own ideas 
and maneuvers to get going further. Assimilating and reconciling their concepts with mine was 
not always easy, particularly while maintaining the course (overarching research theme). One 
very good trait, I have become used to by now is: When you change the way you look at things, things you 
look at, change. They have also transformed me into a disciplined, organized (as well as humble) 
character with loads of other abilities required in the world of science. 
 
Outside workplace, my earnest appreciation goes to my beloved wife Alka and little ones, Aryan, 
Nitya (and Aayra), for their constant reinforcement, inspiration and cooperation. Even though it 
sounded a bit weird when Aryan and Nitya at the age of 4 and 5 years said, ‘Daddy, you are getting 
late for your office’, pushing me out; and ‘Daddy, you need to work more than Richard Lucius’, when I 
worked at home; it was an inspirational push I cherished every day. Alka, for one, has been one 
of the most central persons in my life for the last 20 years, categorically resigning her own dreams 
to support my carrier and build our family in Germany, despite the fact that her heart and mind 
are still in India. Caring for kids during the school and kindergarten holidays, as well as during 
ailment periods and business travels, she bestowed me myriad extra hours of work, for which I 
can never thank her enough. I also sincerely acknowledge my Parents and Family Members in 
India, who have been a major brute force to back my carrier in science. Then there were many 
festive as well as tragic occasions when they all had to put up with my unforeseen absence due to 
academic obligations. Work and Life, both would have been agonizing without your backing.  
 
Second last, I wish to express my sincere gratitude to various funding agencies. This work would 
never have been realized without generous funds from many funding sources, mainly German 
Research Foundation (DFG), Humboldt University, Helmholtz Foundation, International Max-
Planck Research School, National Institute of Health, European Society of Clinical Microbiology 
and Infectious Diseases, European Molecular Biology Organization, Federation of European 
Biochemical Societies and Novartis Animal Health. Last but not least, I am extremely grateful to 
you as a Reader for your patience and time to read this piece of work, which will navigate you 
through my last 13 years of journey. I want to apologize for any sections of this work, which may 
sometime be challenging or perplexing to a non-expert. The excuse is obvious: my voyage through 




7 CURRICULUM VITAE 
 
AWARDS & HONORS 
 
Nov 2015 Young Scientist Award in Microbiology by Robert Koch Foundation (Germany) 
Feb 2015 Indian National Science Academy (INSA) Fellow (University of Delhi, India)  
July 2014 Carl Asmund Rudolphi Medal by the German Society of Parasitology (Germany) 




2016 – 2021  Heisenberg Fellowship by German Research Foundation, Germany  
2006 – 2008  Postdoctoral Fellowship from German Research Foundation (DFG) 
2003 – 2006  Postdoctoral Fellowship from National Institute of Health (NIH), USA 
1999 – 2003  PhD Fellowship from German Research Foundation (DFG) 
1997 – 1999  MS-Biotech Stipend from Ministry of Science, Government of India 
2000 – Present Travel awards from EMBO, FEBS, ESCMID, IUBMB, WAAVP, COST857, 




2015 – 2018 Optogenetic dissection of cyclic NMP signaling in T. gondii: GU 1100/7-1 from 
German Research Foundation, 197.550€ 
 
2015 – 2019 Cyclic NMP signaling and metabolic regulation in T. gondii: GRK2046/A2 from 
German Research Foundation, 133.272€ 
 
2014 – 2017 Synthesis vs. import of host-derived phospholipids by T. gondii: GU1100/4-1 from 
German Research Foundation; co-PI: Maik Lehmann, 319.900€ 
 
2013 – 2016 Carbon metabolisms of acute and chronic stages of T. gondii: GU1100/3-1 from 
German Research Foundation, 159.150€ 
 
2010 – 2012 Phosphatidylcholine synthesis as a drug target in T. gondii: Young scientist grant 
from European Society of Infectious Diseases and Microbiology, 20.000€ 
 
2009 – 2014 Biogenesis of inositol-lipids in T. gondii: GRK1121/A7 from German Research 
Foundation, co-PI: Andreas Herrmann (HU, Berlin), 181.000€ 
 
2009 – 2013  Modeling of lipid biogenesis in Toxoplasma-infected human cell 
SBF618/C7 from German Research Foundation, co-PIs: Herrmann Holzhütter 
(Charité, Berlin) and Richard Lucius (HU, Berlin), 410.700€ 
 
2009 – 2011  High-throughput anti-coccidian drug screening using YFP-parasite 
Novartis Animal Healthcare, co-PI: Richard Lucius (HU, Berlin), 32.725€ 
 
2009 – 2011  In vivo parasite-host interactions in the Eimeria-mouse model 
Awarded to Manuela Schmid and Nishith Gupta/Richard Lucius (Host labs at 
HU, Berlin) by Helmholtz Foundation, Germany, ~120.000€ 
 
2008 – 2010  Central carbon metabolism of T. gondii 
Awarded to Martin Blume and Nishith Gupta/Richard Lucius (Host labs at HU, 






2009 – Present Summer Semester module for Master students (MB-A05): Biochemistry and Cell 
Biology of Parasites 14 lectures, 2-weeks practical course and journal club,  
Organized jointly with Kai Matuschewski (Humboldt University, Berlin) 
 
2010 – Present Winter Semester module for Master students (MB-A04): Molecular Manipulation 




2008   Pathogen-Host-Interplay, International Summer School (Berlin) 
Funding: FEBS, DAAD and ESCMID, Co-organizer: Martina Sick 
Volume: 52.000 Euros plus 15 International Travel Fellowships  
 
2007   Pathogen-Host-Interplay, International Summer School (Berlin) 
   Funding: Center of Infection and Immunity (ZIBI), Co-organizer: Martina Sick 
    
2006 – 2008  International Colloquiums in Infection Biology for PhD students (Berlin) 





2015 – Present  Bingjian Ren: CRISPR/Cas9-assisted reverse genetics in E. falciformis 
2015 – Present  Laura Radtke: Stage-specific metabolism and signaling in T. gondii 
2015 – Present  Ozlem Günay: Genetic dissection of cGMP signaling in T. gondii 
2014 – Present  Matthias Noll: Optogenetic dissection of cAMP signaling in T. gondii 
2014 – Present  Arunakar Kuchipudi: Lipid-regulated calcium homeostasis in T. gondii 
2012 – 2016  Richard Nitzsche: Central carbon metabolism of T. gondii 
2012 – 2016  Pengfei Kong: Synthesis and roles of phospholipids in T. gondii and E. falciformis 
2010 – 2014  Anne Hartmann: Phosphatidylethanolamine biogenesis in T. gondii  
2009 – 2014  Ruben Dario Arroyo-Olarte: Phosphatidylthreonine biogenesis in T. gondii  
2009 – 2012  Manuela Schmid: Host determinants of Eimeria development in mouse model  
2009 – 2011  Vera Sampels: Phosphatidylcholine biogenesis in T. gondii 
2008 – 2010  Martin Blume: Sugar metabolism of T. gondii and P. berghei   
 
MS, BS and Internship students (on topics related to aforementioned PhD students)  
 
2006 – Present Lisa-Elena Pfluger, Diana Zimmermann, Mareen Lüthen, Julieta Cuellar, 
Stefanie Brandt, Theresa Ring, Laura Radtke, Julian Kreibich, Aline Hössler, 
Leska Balken, Fatima Hedar, Lucas Niedersen, Ludmila Lobkowicz, Maximilian 
Tischer, Ulrich Sternberg, Heidy Narvaez, Tobias Kletter, Christoph 
Uffermann, Stefania Chiocchetti, Maria Hellmund, Nicola Schaltenberg, 
Friederike Hoffmann, Katharina Imkeller, Bilal Qureshi, Natalie Hofmann, 
Bernadette Nickl, Clemens Falker, Stephan Marquardt, Ines Heyn, Christina 
Wangen, Jennifer Oduro, Marjorie Linares, Kathrin Frenzel, Manuela Schmid, 






April 2016  Make it or take it – Phospholipid biogenesis in Toxoplasma gondii 
   Infection Immunology Meets Molecular Microbiology, Erlangen, Germany 
 
June 2015  Phosphatidylthreonine and lipid-mediated control of parasite virulence 
   Toxoplasmosis Conference, Gettysburg, USA 
 
Jan/Feb 2015  A lethal intimacy – Metabolic basis of parasite-host interplay and infidelity 
   IIS and NCBS (Bangalore), CDRI (Lucknow), JNU (New Delhi), India 
 
Nov 2014  Optogenetics-mediated regulation of cAMP signaling in Toxoplasma gondii 
   International Workshop on Opportunistic Protists, Seville, Spain 
 
Nov 2014  Metabolic basis of parasite-host interplay and infidelity 
   Veterinary University of Madrid, Spain 
 
May 2014  Metabolic basis of obligate intracellular parasitism 
   University of Edinburgh, Scotland, UK 
 
April 2014  Opposing functions of the mouse IFNγ signaling during Eimeria infection 
   International Congress on Infectious Diseases, Cape Town, South Africa  
 
November 2013 Make it or take it – Lipid biogenesis in Toxoplasma gondii 
   University of Utrecht, The Netherlands  
 
November 2013 Opposing roles of IFNγ signaling during Eimeria infection 
   Apicowplexa Meeting, Kusadasi, Turkey  
 
September 2012 Optogenetic control of cytosolic cAMP in Toxoplasma gondii 
   EMBO Meeting, Nice, France 
 
December 2010  Toxoplasma gondii: A model organism to explore pathogen-host interactions 
   University of Veterinary Medicine, Vienna, Austria  
 
August 2010  Phospholipid biogenesis in Toxoplasma gondii  
   International Congress of Parasitology (ICOPA), Melbourne, Australia  
 
August 2009  Toxoplasma gondii secretes a soluble PtdSer decarboxylase  
   World Association for Veterinary Parasitology (WAVP), Calgary, Canada 
 
June 2008  Membrane biogenesis in Toxoplasma gondii  
   COST857 Workshop on Apicomplexan Parasites, Crete, Greece  
 
December 2006  Membrane biogenesis in Toxoplasma gondii  




2015 – Present  Robert Koch Foundation, Germany 
2014 – Present  German Society of Parasitology (DGP), Germany 
2001 – Present  Biochemical Society (FEBS constituent), United Kingdom 
2007 – Present  European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 
2007 – Present  International Society of Infectious Diseases (ISID) 






5-yrs Citations  656 (Source: Google Scholar) 
Editorial Board Microbial Cell 
Journal Reviewer Elsevier, FEBS, FEMS, JBC, PLoS Journals, Wiley, ASM 
Grant Reviewer MRC, BBSRC, Welcome Trust – DBT 
Feature Article 1) Exploiting the Host: International Innovation Magazine Sept 2013 
 2) Optogenetics in infection research (due in 2018) 
Patents Genetically attenuated vaccine against Toxoplasmosis gondii and commercial usage 




(1) Sugi T, Ma YF, Tomita T, Murakoshi F, Eaton MS, Yakubu R, Han B, Tu V, Kato K, Kawazu SI, 
Gupta N, Suvorova ES, White MW, Kim K, Weiss LM (2016) Toxoplasma gondii cAMP-dependent 
protein kinase subunit 3 is involved in the switch from tachyzoite to bradyzoite development. mBio, 7(3): 
e00755-16 
 
(2) Kuchipudi A, Arroyo-Olarte RD, Hoffmann F, Brinkmann V, Gupta N (2016) Optogenetic monitoring 
of the parasite calcium identifies a phosphatidylthreonine-regulated ion homeostasis in Toxoplasma gondii. 
Microbial Cell, 3(5), 215-23 
 
(3) Arroyo-Olarte RD and Gupta N (2016) Phosphatidylthreonine: an exclusive phospholipid regulating 
calcium homeostasis and virulence in a parasitic protest. Microbial Cell, 3(5): 189-90 
 
(4) Nitzsche R, Zagoriy V, Lucius R, Gupta N (2016); Metabolic cooperation of glucose and glutamine is 
essential for the lytic cycle of obligate intracellular parasite Toxoplasma gondii. Journal of Biological Chemistry, 
291(1): 126-41 
 
(5) Arroyo-Olarte RD, Burrowers JF, Kuchipudi A, Helms JB, Biswas A, Dunay IR, Lucius R, Gupta N 
(2015); Phosphatidylthreonine and lipid-mediated control of parasite virulence. PLoS Biology, 13 (11):  
e1002288 
 
(6) Blume M, Nitzsche R, Sternberg U, Gerlic M, Masters SL, Gupta N, McConville MJ (2015); A 
Toxoplasma gondii gluconeogenic enzyme contributes to robust central carbon metabolism and is essential 
for replication and virulence. Cell Host & Microbe, 18(2): 210-20 
 
(7) Hartmann A, Hellmund M, Lucius R, Voelker DR, Gupta N (2014); Phosphatidylethanolamine 
synthesis in the parasite mitochondrion is required for efficient growth but dispensable for survival of 
Toxoplasma gondii. Journal of Biological Chemistry, 289(10): 6809-24 
 
(8) Schmid M, Heitlinger E, Spork S, Mollenkopf HP, Lucius R, Gupta N (2014); Eimeria falciformis infection 
of the mouse caecum identifies opposing roles of IFNγ-regulated host pathways for the parasite 
development. Mucosal Immunology, 7(4): 969-82 
 
(9) Hartmann A, Arroyo-Olarte RD, Imkeller K, Hegemann P, Lucius R, Gupta N (2013); Optogenetic 
modulation of an adenylate cyclase in Toxoplasma gondii demonstrates a requirement of parasite cAMP for 
host-cell invasion and stage differentiation. Journal of Biological Chemistry, 288(19): 13705-17 
 
(10)  Qureshi B, Hoffmann N, Arroyo-Olarte RD, Nickl B, Höhne W, Jungblut P, Lucius R, Scheerer P, 
Gupta N (2013); Dynein Light Chain 8a of Toxoplasma gondii, a unique conoid-localized β-strand-swapped 




(11) Gupta N, Hartmann A, Lucius R, Voelker DR (2012) The obligate intracellular parasite Toxoplasma gondii 
secretes a soluble phosphatidylserine decarboxylase. Journal of Biological Chemistry, 287(27): 22938-47 
 
(12) Schmid M, Lehmann MJ, Lucius R, Gupta N (2012) Apicomplexan parasite, Eimeria falciformis, co-opts 
host tryptophan catabolism for life cycle progression in the mouse. Journal of Biological Chemistry, 287(24): 
20197-207 
 
(13) Sampels V, Hartmann A, Dietrich I, Coppens I, Sheiner L, Striepen B, Herrmann A, Lucius R, Gupta 
N (2012) Conditional mutagenesis of a novel choline kinase demonstrates the plasticity of 
phosphatidylcholine biogenesis and gene expression in Toxoplasma gondii. Journal of Biological Chemistry, 
287(20): 16289-99 
 
(14) Blume M, Hliscs M, Contreras D, Sanchez M, Landfear S, Lucius R, Matuschewski K, Gupta N (2011) 
A constitutive pan-hexose permease in Plasmodium and models for high-throughput screening of anti-
malarial sugar analogs. FASEB J, 25(4): 1218-29 
 
(15) Shao D, Liu Y, Liu X, Zhu L, Cui Y, Cui A, Qiao A, Kong X, Liu Y, Chen Q, Gupta N, Fang F, Chang 
Y (2010) PGC-1β-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 
and ERRα. Mitochondrion, 10(5): 516–27 
 
(16) Zhu LL, Liu Y, Cui AF, Shao D, Liang JC, Liu XJ, Chen Y, Gupta N, Fang FD, Chang Y (2010) PGC-
1α coactivates estrogen receptor α to induce the expression of glucokinase. American Journal of Physiology 
Endocrinology Metabolism, 298(6): E1210–8 
 
(17) Kong X, Fan H, Liu X, Wang R, Liang J, Gupta N, Chen Y, Fang F, Chang Y (2009) Peroxisome 
proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5'-deoxy-
5-fluorouridine in cancer cells through induction of uridine phosphorylase. Molecular Pharmacology, 76(4): 
854-60 
 
(18) Blume M, Contreras DR, Landfear S, Fleige T, Soldati DF, Lucius R, Gupta N (2009) Host-derived 
glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by 
glutaminolysis. Proceedings of National Academy of Sciences USA, 106(31): 12998–3003 
 
(19) Liu X, Feng Q, Chen Y, Zuo J, Gupta N, Chang Y, Fang F (2009) Proteomics-based identification of 
differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients. 
Journal of Proteome Research, 8(3): 1255-62 
 
(20) Jiang ZB, Song HT, Gupta N, Ma LX, Wu ZB (2007) Cell surface display of functionally active lipases 
from Yarrowia lipolytica in Pichia pastoris. Protein Expression Purification, 56(1): 35-9 
 
(21) Yang C, Yang Y, Gupta N, Liu X, He A, Liu L, Zuo J, Chang Y, Fang F (2007) Pentaspan membrane 
glycoprotein, prominin-1, is involved in glucose metabolism and cytoskeleton alteration. Biochemistry (M), 
72(8): 854-62 
 
(22) He A, Zhu L, Gupta N, Chang Y, Fang F (2007) Overexpression of miR-29, highly up-regulated in 
diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Molecular Endocrinology, 21(11): 2785-94 
 
(23) Liu XJ, Yang C, Gupta N, Zuo J, Chang YS, Fang FD (2007) Protein kinase C-ζ regulation of GLUT4 
translocation by actin remodeling in CHO cells. Journal of Molecular Medicine, 85(8): 851–61 
 
(24) Gupta N, Zahn MM, Coppens I, Joiner KA, Voelker DR (2005) Selective disruption of 
phosphatidylcholine metabolism of the intracellular parasite Toxoplasma gondii arrests its growth. Journal of 




8 DECLARATIONS (ERKLÄRUNG) 
 
(a) Ich versichere hiermit an Eidesstatt, dass ich die Habilitationsschrift bzw. eine Mehrzahl von 
Fachpublikationen mit dem einer Habilitationsschrift entsprechenden wissenschaftlichen 
Gewicht selbständig angefertigt habe. 
 
(b) Hiermit erkläre ich, dass anderweitig kein Habilitationsverfahren durchgeführt wird. Falls 
bereits ein Habilitationsverfahren durchgeführt wurde, finden Sie die vollständigen Angaben 
über dessen Ausgang auf einem gesonderten Blatt.  
 
(c) Ich erkläre die Kenntnisnahme der dem Verfahren zugrunde liegenden Habilitationsordnung 
der Lebenswissenschaftlichen Fakultät der Humboldt-Universität zu Berlin vom 21. März 2016.  
 
(d) Weiterhin erkläre ich, dass die Regeln der guten wissenschaftlichen Praxis, wie sie in der 
„Satzung der Humboldt-Universität zu Berlin zur Sicherung guter wissenschaftlicher Praxis und 
über den Umgang mit Vorwürfen wissenschaftlichen Fehlverhaltens“ in der jeweils geltenden 
Fassung festgelegt sind, eingehalten wurden.  
 









9 PUBLICATIONS (REPRESENTATIVE FULL-TEXT ARTICLES) 
 
Following pages contain the full text of selected original research articles partly embodying this 
work. Other full-text publications with supplementary datasets can be accessed at: 
 
https://www.ncbi.nlm.nih.gov/pubmed/?term=Nishith+Gupta 
 
https://www.researchgate.net/profile/Nishith_Gupta 
 
  
 
 
 
